DEF 14A
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the Securities
Exchange Act of 1934 (Amendment No. )
Filed by the Registrant þ
Filed by a Party other than the Registrant o
Check the appropriate box:
o |
|
Preliminary Proxy Statement |
o |
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
þ |
|
Definitive Proxy Statement |
o |
|
Definitive Additional Materials |
o |
|
Soliciting Material Pursuant to §240.14a-12 |
SAFEGUARD SCIENTIFICS, INC.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
þ |
|
No fee required. |
o |
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. |
|
(1) |
|
Title of each class of securities to which transaction applies: |
|
|
|
|
|
|
|
|
|
|
|
(2) |
|
Aggregate number of securities to which transaction applies: |
|
|
|
|
|
|
|
|
|
|
|
(3) |
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act
Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was
determined): |
|
|
|
|
|
|
|
|
|
|
|
(4) |
|
Proposed maximum aggregate value of transaction: |
|
|
|
|
|
|
|
|
|
|
|
(5) |
|
Total fee paid: |
|
|
|
|
|
|
|
|
|
o |
|
Fee paid previously with preliminary materials. |
|
o |
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2)
and identify the filing for which the offsetting fee was paid previously. Identify the
previous filing by registration statement number, or the Form or Schedule and the date of its
filing. |
|
(1) |
|
Amount Previously Paid: |
|
|
|
|
|
|
|
|
|
|
|
(2) |
|
Form, Schedule or Registration Statement No.: |
|
|
|
|
|
|
|
|
|
|
|
(3) |
|
Filing Party: |
|
|
|
|
|
|
|
|
|
|
|
(4) |
|
Date Filed: |
|
|
|
|
|
|
|
|
|
TABLE OF CONTENTS
435 Devon Park Drive, Building 800
Wayne, PA 19087-1945
|
|
|
Phone:
|
|
610-293-0600 |
Toll-Free:
|
|
877-506-7371 |
Fax:
|
|
610-293-0601 |
Internet: www.safeguard.com
SAFEGUARD SCIENTIFICS, INC.
NOTICE OF ANNUAL MEETING OF SHAREHOLDERS
Dear Shareholder:
You are invited to attend the Safeguard Scientifics, Inc. 2011 Annual Meeting of Shareholders.
|
|
|
DATE:
|
|
May 26, 2011 |
|
|
|
TIME:
|
|
8:00 a.m. Eastern Time |
|
|
|
PLACE:
|
|
Dolce Valley Forge |
|
|
301 West DeKalb Pike |
|
|
King of Prussia, PA 19406 |
|
|
610-337-1200 |
|
|
|
RECORD DATE:
|
|
Only shareholders who owned stock at the close of business on
April 8, 2011, can vote at this meeting and any adjournments that
may take place. |
|
|
|
ITEMS OF BUSINESS:
|
|
1. Vote on the election of eight directors; |
|
|
|
|
|
2. Vote on the ratification of KPMG LLP
as our independent registered public accounting firm for 2011; |
|
|
|
|
|
3. Vote on a non-binding, advisory
resolution concerning the compensation of our named executive
officers; |
|
|
|
|
|
4. Vote on a non-binding, advisory basis
concerning the frequency of future advisory votes concerning
executive compensation; and |
|
|
|
|
|
5. Consider such other business as may
properly come before the meeting. |
We also will report on Safeguards business results and other matters of interest to our
shareholders. You will have an opportunity at the meeting to ask questions, make comments and meet
our management team.
If you do not vote your shares on proposals one (Election of Directors), three (Executive
Compensation) and four (Frequency of Compensation Vote), your brokerage firm will not be able to
vote your shares for you. As a result, your shares will remain unvoted. Therefore, it is more
important than ever that you vote your shares for all proposals.
We encourage you to read the proxy statement and submit your proxy or voting instructions as soon
as possible to ensure your representation at the annual meeting, regardless of whether you plan to
attend in person. You may vote:
(1) by completing, signing, dating and returning your proxy card or voting instruction form in
the prepaid envelope provided; or (in most cases)
(2) by telephone as follows:
Shareholders of Record: Within the USA, US territories and Canada, call 1-800-652-VOTE (8683)
Owners of shares held in street name: call the number indicated in the box at the top
left hand side of your voting instruction form;
or
(3) by Internet as follows:
Shareholders of Record: go to www.investorvote.com/SFE.
Owners of shares held in street name: go to www.proxyvote.com.
For specific instructions on how to vote your shares, please refer to the section entitled
Questions and Answers about the Meeting and the Proposals beginning on page 1 of the proxy
statement and the instructions on the proxy card or voting instruction form.
IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THE
SHAREHOLDER MEETING TO BE HELD ON MAY 26, 2011
The proxy statement and our annual report for the fiscal year ended December 31, 2010, are available at
www.safeguard.com/proxy.
This notice of annual meeting, proxy statement, accompanying proxy card, and 2010 annual report
will be mailed to shareholders beginning on or about April 21, 2011, in connection with the
solicitation of proxies by our Board of Directors.
By Order of the Board of Directors,
Deirdre Blackburn
Secretary
April 13, 2011
PROXY STATEMENT FOR ANNUAL MEETING OF SHAREHOLDERS
QUESTIONS AND ANSWERS ABOUT
THE ANNUAL MEETING AND THE PROPOSALS
Q: |
|
When and where is the annual meeting? |
A: |
|
Safeguards annual meeting is being held on May 26, 2011, at 8:00 a.m. Eastern Time at the Dolce Valley Forge, 301 West
DeKalb Pike, King of Prussia, PA 19406. You may obtain directions to the meeting at www.safeguard.com/dolce. |
|
Q: |
|
Do I need a ticket or proof of Safeguard ownership to attend the annual meeting? |
|
A: |
|
You will not need a ticket to attend the annual meeting. However, only persons with evidence of stock ownership, or who
are guests of Safeguard, may attend and be admitted to the annual meeting. Photo identification, such as a valid drivers
license or passport, will be required. If you are not a shareholder of record but hold shares through a broker, trust
company, bank or other nominee, you will need to provide proof of beneficial ownership on the record date, such as a legal
proxy from your broker, trust company, bank or other nominee, your most recent brokerage account statement prior to April
8, 2011 (the record date for determining the shareholders entitled to vote at the annual meeting), a copy of the voting
instruction form provided by your broker, trustee or other nominee, or other similar evidence of ownership. If you do not
have photo identification and proof that you own Safeguard shares, you will not be admitted to the annual meeting. |
|
Q: |
|
Why am I receiving these materials? |
|
A: |
|
You are receiving Safeguards annual report, notice of annual meeting, proxy statement and a proxy card or voting
instruction form because you owned shares of Safeguard stock on April 8, 2011. This proxy statement contains detailed
information relating to the proposals on which we would like you, as a shareholder, to vote. The proxy card or voting
instruction form is used for voting on the proposals. The annual report, notice of annual meeting and proxy statement also
are available on the Internet at www.safeguard.com/proxy. |
|
Q: |
|
How many shares must be present to hold the annual meeting? |
|
A: |
|
To hold the annual meeting, a quorum must be present. A quorum is a majority of our outstanding shares, which may be
represented at the annual meeting either in person or by proxy. Proxies received but marked as abstentions or containing
broker non-votes on a particular matter will be included in the calculation of the number of shares entitled to vote for
the purpose of determining the presence of a quorum. |
|
Q: |
|
What am I voting on? |
|
A: |
|
You are being asked to vote on: |
|
1. |
|
The election of eight directors who have been nominated to serve on Safeguards Board
of Directors (Board); |
|
2. |
|
A proposal to ratify KPMG LLP as Safeguards independent registered public accounting
firm for the 2011 fiscal year; |
|
3. |
|
A proposal to approve, by non-binding, advisory vote, the compensation paid to
Safeguards named executive officers as described in this proxy statement; and |
|
4. |
|
A proposal to approve, by non-binding, advisory vote, the frequency of future advisory
votes concerning executive compensation. |
1
We also will consider other business that properly comes before the annual meeting.
Q: |
|
How does Safeguards Board of Directors recommend I vote? |
|
A: |
|
Unless you instruct otherwise on your proxy card, the persons named as
proxy holders on the proxy card will vote in accordance with the
recommendations of Safeguards Board. The Board recommends a vote: |
|
|
|
FOR the election of each Board nominee; |
|
|
|
|
FOR the proposal to ratify KPMG LLP as Safeguards independent registered public
accounting firm for the 2011 fiscal year; |
|
|
|
|
FOR the approval, in a non-binding, advisory vote, of Safeguards executive
compensation as described in the proxy statement; and |
|
|
|
|
FOR future non-binding, advisory votes concerning executive compensation to take place
on an annual basis. |
Our Board also requests discretionary authority to cumulate votes in the election of directors
and to vote on any other matters that may properly arise at the annual meeting. If our Board
gives no recommendation on any such matter, the proxy holders will vote in their own discretion.
Q: |
|
How many votes do I have? |
A: |
|
Each share of Safeguard common stock outstanding on the record date is entitled to vote on all items being voted upon at the annual
meeting. On the record date, we had 20,667,702 shares of common stock issued and outstanding. |
|
|
|
Every shareholder may cast one vote for each share owned on the record date. In the election of directors, shareholders may elect to
cumulate their votes as described below under What does cumulative voting mean? |
|
Q: |
|
What does cumulative voting mean? |
|
A: |
|
Cumulative voting applies only in the election of directors. It means that you may cast a number of votes equal to the number of
Safeguard shares you own multiplied by the number of directors to be elected. For example, since eight directors are standing for
election at the annual meeting, if you hold 100 shares of Safeguard stock, you may cast 800 votes (eight times 100) in the election of
directors. You may distribute those votes among as few or as many of the eight nominees as you wish. In other words, in the example
provided, you may cast all 800 votes FOR one nominee or allocate your 800 votes among two or more nominees, as long as the total equals
800 votes. |
|
|
|
If you received a proxy card and wish to vote cumulatively, you must: |
|
|
|
Write the words cumulate for in the space provided under item 1 of the proxy card; and |
|
|
|
Write the name of each nominee and the number of votes to be cast for each nominee in that space. |
If you vote cumulatively, please check to be sure that the votes you cast add up to the number
of shares you own multiplied by eight. If the number of votes does not add up correctly, your
votes will not be counted until a properly completed proxy card has been received.
The cumulative voting feature for the election of directors also is available by voting in
person at the annual meeting; however, it is not available if you vote by telephone or
the Internet. If you are the beneficial owner of shares held in street name and wish to vote
cumulatively, you will need to contact your broker, bank or other nominee holder of your shares.
2
Q: |
|
What is the difference between holding shares as a shareholder of record and as a beneficial owner? |
A: |
|
Most of Safeguards shareholders hold their shares through a broker, bank or other nominee rather than directly in their
own name. There are important distinctions between shares held of record and those owned beneficially. |
|
|
|
Shareholder of Record |
|
|
|
If your shares are registered directly in your name with Safeguards transfer agent, Computershare, you are considered the
shareholder of record with respect to those shares, and these proxy materials are being sent to you directly by Safeguard.
As a shareholder of record, you have the right to grant your voting proxy directly
to Safeguard or to vote in person at the annual meeting. If you are a shareholder of record,
Safeguard has enclosed a proxy card for your use in voting your shares. |
Beneficial Owner
If your shares are held in street name (such as in a brokerage account or by another nominee,
such as a bank or trust company), you are considered the beneficial owner of the shares, and
these proxy materials, together with a voting instruction form, are being forwarded to you by
your broker or other nominee. As a beneficial owner, you have the right to direct your broker
or other nominee how to vote your shares, but unless you receive a proxy from your broker, you
cannot vote your shares directly or by proxy you must instruct your broker or other nominee
as to how to vote your shares. You also are invited to attend the annual meeting. To vote your
shares at the annual meeting, you will need a legal proxy from your broker or other nominee
authorizing you to vote at the annual meeting.
Q: |
|
How do I vote my shares? |
A: |
|
If you are a shareholder of record, there are three ways for you to vote by proxy: |
|
1. |
|
Log on to the Internet at www.investorvote.com/SFE and follow the instructions at that
site; |
|
2. |
|
Within the USA, US territories and Canada, call 1-800-652-VOTE (8683) and follow the
instructions; or |
|
3. |
|
Sign and date each proxy card you receive, mark the boxes indicating how you wish to
vote, and return the proxy card in the prepaid envelope provided. |
Telephone and Internet voting will close at 11:59 p.m. Eastern Time the day prior to the annual
meeting date.
If you sign your proxy card but do not mark any boxes showing how you wish to vote, Brian J.
Sisko and Deirdre Blackburn, as the proxies designated by our Board to act on behalf of
shareholders, will vote your shares and cumulate your votes as recommended by our Board and, in
their discretion, will vote on any other matters which may properly arise at the annual meeting.
If you are the beneficial owner of shares held in street name, you will receive a voting
instruction form directly from your broker, bank or other nominee describing how to vote your
shares. This form will, in most cases, offer you three ways to vote:
|
1. |
|
Via the Internet at www.proxyvote.com; |
|
2. |
|
By telephone (call the number indicated in the box at the top left hand side of your
voting instruction form); or |
|
3. |
|
By completing, signing and returning the voting instruction form in the accompanying
prepaid envelope. |
You should carefully follow any instructions sent by your broker, bank or other nominee to
ensure that your instructions are received and your votes are cast as directed.
Whether you are a shareholder of record or the beneficial owner of the shares, you will need to
have your proxy card or voting instruction form in hand when you call or log on to the Internet.
3
Q: |
|
What do I do if I change my mind after I vote my shares? |
A: |
|
If you are a shareholder of record, you may change your vote at any
time prior to the vote at the annual meeting by: |
|
1. |
|
Re-voting by telephone or via the Internet (only your latest vote will be counted); |
|
2. |
|
Submitting another proxy card with a later date (again, only your latest vote will be
counted); |
|
3. |
|
Sending written notice to our Secretary (which must be received at our corporate
headquarters on or before the business day prior to the annual meeting) stating that you
would like to revoke (that is, cancel) your proxy; or |
|
4. |
|
Voting in person at the annual meeting. |
If you are the beneficial owner of shares held in street name, you may submit new voting
instructions by following the instructions provided by your broker, bank or other nominee. You
also may vote in person at the annual meeting if you obtain a legal proxy from your broker or
other nominee authorizing you to vote at the annual meeting.
Attendance at the annual meeting will not cause your previously granted proxy to be revoked
unless you specifically request such a revocation. If you are a shareholder of record and wish
to vote at the annual meeting, you may do so by presenting your completed proxy card or ballot
to the judge of election. If you are a beneficial owner of shares held in street name and wish
to vote at the annual meeting, you must present a legal proxy from your broker or other nominee
to the judge of election along with your ballot.
Q: |
|
What is the required vote for a proposal to pass? |
A: |
|
Election of Directors. The eight nominees who receive the highest
number of FOR votes at the annual meeting will be elected as
directors. A properly executed proxy that withholds authority to vote
with respect to the election of one or more directors will not be
voted with respect to the director or directors indicated and will not
be taken into account in determining the outcome of the election;
however, it will be counted for purposes of determining whether there
is a quorum. |
Other Proposals. For the ratification of the appointment of our independent registered public
accounting firm, the non-binding, advisory vote on the compensation paid to Safeguards named
executive officers, the non-binding, advisory vote on the frequency of future advisory votes on
executive compensation, and any other proposal that may be properly brought before the annual
meeting, the affirmative vote of a majority of the votes cast by all the shareholders entitled
to vote for the proposal will be required, so long as a quorum representing a majority of our
outstanding voting stock is present, either in person or by proxy.
A properly executed proxy marked ABSTAIN with respect to any proposal will be counted for
purposes of determining whether there is a quorum. However, under Pennsylvania law, a proxy
marked ABSTAIN is not considered a vote cast. Accordingly, an abstention will have no effect
on proposals included in this proxy statement. Broker non-votes (which are explained below) are
not counted in the tally of votes FOR or AGAINST a proposal and, therefore, have no effect
on the proposals, assuming a quorum is present.
Q: |
|
What effect will the results of the non-binding, advisory votes regarding executive compensation and the frequency of
future votes regarding executive compensation have on Safeguard? |
According to the rules of the United States Securities and Exchange Commission (SEC), the advisory votes to approve the
compensation of Safeguards named executive officers and the frequency of future advisory votes on executive compensation
are not binding on Safeguard. However, Safeguards Board and Compensation Committee will consider the results of these
advisory votes in making future decisions regarding Safeguards compensation policies, the compensation of Safeguards
named executive officers, and the frequency of future advisory votes on executive compensation.
4
Q: |
|
Will my shares be voted if I do not sign and return my proxy card or voting instruction form? |
A: |
|
They could be. If you are a shareholder of record and do not provide a proxy, your shares will not be voted unless you
attend the annual meeting and vote your shares. If you are a beneficial owner of shares held in street name and you do not
provide your broker with voting instructions, your broker or other nominee may either use its discretion to vote your
shares on routine matters or leave your shares unvoted. The ratification of the appointment of our independent
registered public accounting firm is considered routine by the New York Stock Exchange (NYSE). However, for matters
deemed non-routine by the NYSE, your broker or other nominee would not be able to vote without your instructions, in
which case your shares would be considered broker non-votes on that particular matter. An uncontested director election
is considered a non-routine matter for which brokers do not have discretionary authority to vote shares held by an account
holder. Additionally, as required by Section 957 of the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010
(the Dodd-Frank Act), the advisory votes on executive compensation and on the frequency of such votes also are considered
non-routine matters for which brokers do not have discretionary authority to vote shares held by account holders. |
|
Q: |
|
Who will count the votes? |
|
A: |
|
A representative of Safeguard will count the votes and act as the judge of election. |
|
Q: |
|
What does it mean if I get more than one proxy card or voting instruction form? |
|
A: |
|
It may mean that you have multiple accounts at the transfer agent or hold your shares in more than one brokerage account.
Please provide voting instructions for all proxy cards and voting instruction forms that you receive. If you are a
shareholder of record, we encourage you to contact our transfer agent to obtain information about how to combine your
accounts. You may contact our transfer agent at the following address and telephone numbers: |
Computershare Trust Company, N.A.
P. O. Box 43078
Providence, RI 02940-3078
|
|
|
Toll Free (U.S., Canada, Puerto Rico):
|
|
800-736-3001 |
International:
|
|
781-575-3100 |
Hearing Impaired TDD
|
|
800-952-9245 |
If you are a shareholder of record, you also can find information on transferring shares and
other useful shareholder information on our transfer agents web site at
www.computershare.com/investor
Q: |
|
What is householding and how does it affect me? |
A: |
|
If you and other residents at your mailing address are the beneficial
owner of shares held in street name, your broker, bank or other
nominee may have notified you that your household will receive only
one annual report and proxy statement for each company in which you
hold stock through that broker, bank or other nominee. This practice
is commonly referred to as householding and potentially provides
extra convenience for shareholders and cost savings for companies.
Unless you responded that you did not want to participate in
householding, you were deemed to have consented to the process.
Therefore, your broker or other nominee will send only one copy of our
annual report and proxy statement to your address; however, each
shareholder in your household should continue to receive a separate
voting instruction form. |
If you are the beneficial owner of shares held in street name and you would like to receive your
own set of our annual report and proxy statement in the future, or if you share an address with
another Safeguard shareholder and together both of you would like to receive only a single set
of Safeguard annual documents, please contact Broadridge by telephone at 1-800-542-1061. Be
sure to provide Broadridge with your name, the name of your brokerage firm, bank or other
nominee, and your account number.
If you are currently subject to householding and would like to receive an individual copy of
this years annual report or proxy statement, we will promptly send a copy to you if you send a
written request to Safeguard Scientifics, Inc., Attention: Investor Relations, 435 Devon Park
Drive, Building 800, Wayne, PA 19087-1945 or call 1-877-506-7371.
5
STOCK OWNERSHIP OF CERTAIN BENEFICIAL OWNERS,
DIRECTORS AND OFFICERS
The following table shows the number of shares of Safeguard common stock beneficially owned as of
March 31, 2011 (unless otherwise indicated), by each person known to us to be the beneficial owner
of more than 5% of our outstanding shares of common stock, our directors, persons named in the
Summary Compensation Table in this proxy statement, and our directors and executive officers as a
group. For purposes of reporting total beneficial ownership, shares that may be acquired within 60
days of March 31, 2011, through the exercise of Safeguard stock options are included. On March 31,
2011, there were 20,666,236 shares of common stock outstanding and 971,799 shares underlying stock
options held by executive officers and directors as a group that were exercisable within 60 days of
March 31, 2011.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares |
|
|
|
|
|
|
|
|
|
Outstanding |
|
|
|
|
|
|
Beneficially |
|
|
|
|
|
|
|
|
|
Shares |
|
|
Options |
|
|
Owned Assuming |
|
|
Percent of |
|
|
Other Stock-Based |
|
|
|
Beneficially |
|
|
Exercisable |
|
|
Exercise of |
|
|
Outstanding |
|
|
Holdings (2) |
|
Name |
|
Owned |
|
|
Within 60 Days |
|
|
Options |
|
|
Shares (1) |
|
|
Vested |
|
|
Unvested |
|
Blackrock, Inc.
40 East 52nd Street
New York, NY 10022 |
|
|
1,269,935 |
|
|
|
|
|
|
|
1,269,935 |
|
|
|
6.17 |
% |
|
|
|
|
|
|
|
|
Dimensional Fund Advisors LP
1299 Ocean Avenue
Santa Monica, CA 90401 |
|
|
1,104,690 |
|
|
|
|
|
|
|
1,104,690 |
|
|
|
5.36 |
% |
|
|
|
|
|
|
|
|
First Manhattan Co.
437 Madison Avenue
New York, NY 10022 |
|
|
1,135,314 |
|
|
|
|
|
|
|
1,135,314 |
|
|
|
5.51 |
% |
|
|
|
|
|
|
|
|
Marshall & Ilsley Corporation
770 North Water Street
Milwaukee, WI 53202 |
|
|
1,227,313 |
|
|
|
|
|
|
|
1,227,313 |
|
|
|
6.00 |
% |
|
|
|
|
|
|
|
|
T. Rowe Price Associates, Inc.
100 East Pratt Street
Baltimore, MD 21202 |
|
|
1,228,563 |
|
|
|
|
|
|
|
1,228,563 |
|
|
|
5.90 |
% |
|
|
|
|
|
|
|
|
Weintraub Capital Management,
L.P.
44 Montgomery St., Suite 4100
San Francisco, CA 94104 |
|
|
1,097,393 |
|
|
|
|
|
|
|
1,097,393 |
|
|
|
5.10 |
% |
|
|
|
|
|
|
|
|
Peter J. Boni |
|
|
116,074 |
|
|
|
348,358 |
|
|
|
464,432 |
|
|
|
2.21 |
% |
|
|
|
|
|
|
|
|
Julie A. Dobson |
|
|
9,666 |
|
|
|
30,830 |
|
|
|
40,496 |
|
|
|
* |
|
|
|
16,503 |
|
|
|
209 |
|
Andrew E. Lietz |
|
|
13,889 |
|
|
|
7,500 |
|
|
|
21,389 |
|
|
|
* |
|
|
|
11,129 |
|
|
|
|
|
George MacKenzie |
|
|
5,529 |
|
|
|
30,830 |
|
|
|
36,359 |
|
|
|
* |
|
|
|
9,696 |
|
|
|
|
|
George D. McClelland |
|
|
1,666 |
|
|
|
29,997 |
|
|
|
31,663 |
|
|
|
* |
|
|
|
40,072 |
|
|
|
221 |
|
Jack L. Messman |
|
|
10,833 |
|
|
|
30,830 |
|
|
|
41,663 |
|
|
|
* |
|
|
|
38,135 |
|
|
|
|
|
John J. Roberts |
|
|
4,921 |
|
|
|
30,830 |
|
|
|
35,751 |
|
|
|
* |
|
|
|
15,376 |
|
|
|
|
|
Robert J. Rosenthal |
|
|
|
|
|
|
19,581 |
|
|
|
19,581 |
|
|
|
* |
|
|
|
10,215 |
|
|
|
128 |
|
James A. Datin |
|
|
78,446 |
|
|
|
179,223 |
|
|
|
257,669 |
|
|
|
1.24 |
% |
|
|
|
|
|
|
|
|
Kevin L. Kemmerer |
|
|
50,184 |
|
|
|
124,276 |
|
|
|
174,460 |
|
|
|
* |
|
|
|
|
|
|
|
|
|
Brian J. Sisko |
|
|
41,207 |
|
|
|
64,804 |
|
|
|
106,011 |
|
|
|
* |
|
|
|
|
|
|
|
|
|
Stephen T. Zarrilli |
|
|
19,735 |
|
|
|
74,740 |
|
|
|
94,475 |
|
|
|
* |
|
|
|
|
|
|
|
|
|
Executive officers and directors
as a group (12 persons) |
|
|
352,150 |
|
|
|
971,799 |
|
|
|
1,323,949 |
|
|
|
6.12 |
% |
|
|
141,126 |
|
|
|
558 |
|
|
|
|
(1) |
|
Each director and named executive officer has the sole power to vote and to dispose of the
shares (other than shares held jointly with an individuals spouse). An * indicates ownership
of less than 1% of the outstanding shares. Shareholding information for BlackRock, Inc.,
Dimensional Fund Advisors, LP, First Manhattan Co., Marshall & Ilsley Corporation, T. Rowe
Price Associates, Inc. and Weintraub Capital Management, L.P. is based on information included
in the Schedule 13G or Schedule 13G/A filed by each such entity as of December 31, 2010 with
the SEC. |
|
(2) |
|
The shares in this column represent deferred stock units that have been credited to each
individual. The deferred stock units, which may not be voted or transferred, are payable, on
a one-for-one basis, in shares of Safeguard common stock following an individuals termination
of service on the Board. See Corporate Governance and Board Matters Board Compensation. |
6
ELECTION OF DIRECTORS
Item 1 on Proxy Card
Our directors are elected annually and serve until the next annual meeting of shareholders. All of
the nominees for this years election are currently serving as directors. Each nominee has
consented to serve until the next annual meeting if elected. If any director is unable to stand
for re-election after distribution of this proxy statement, the Board may reduce its size or
designate a substitute. If the Board designates a substitute, proxies voting on the original
director candidate will be cast for the substituted candidate.
The Board believes that the Board should collectively possess a broad range of skills, expertise,
industry and other knowledge, and business experience that meets the needs of our corporate
strategy and provides effective oversight of our business. The Nominating & Corporate Governance
Committee does not have a formal policy with respect to diversity; however, the Nominating &
Corporate Governance Committees charter provides in relevant part that the committee shall seek
members from diverse backgrounds and goes on to say that the committee will evaluate nominees for
election to our Board with the objective of recommending a group that through its diversity of
experience can provide relevant advice and counsel to management. The Board and the Nominating &
Corporate Governance Committee believe that it is essential that our Board members have diverse
professional experience and differences in viewpoints and skills.
During late 2009 and early 2010, the Boards Nominating & Corporate Governance Committee undertook
a detailed analysis and discussion of the types of skill sets, professional backgrounds and
individual profiles that would be helpful to have represented on the Board. It then also undertook
a skill inventory exercise that included each of Safeguards current Board members and nominees for
re-election. The committee then utilized all of the skill inventory information provided by our
individual directors to make an assessment of the fit between Safeguards needs regarding its Board
composition and the individual attributes of the current Board members. At that time, the
Nominating and Corporate Governance Committee made a determination that each current member of the
Board possessed skills and experience that matched distinct needs of the Board and, therefore,
determined to recommend the nomination of each of such persons for re-election to the Board at our
2010 annual meeting. In early 2011, the same committee revisited its analysis of the Boards needs
and the skill sets and experience of the current individual Board members. Given that our core
business strategy remains the same as in recent prior years, the committee came to the conclusion
and recommended the nomination of each of our current Board members for re-election at our upcoming
annual meeting.
In considering whether to recommend any candidate for inclusion in the Boards slate of recommended
director nominees, the Nominating & Corporate Governance Committee considers the needs of the Board
as a whole as well as the staffing needs of each of its committees. With respect to the nomination
of continuing directors for re-election, an individuals past contributions to the Board also are
considered. The Board monitors the effectiveness of this approach via an annual internal board and
peer assessment, as well as ongoing director succession planning discussions by the Board and its
Nominating & Corporate Governance Committee.
All of our directors bring to our Board executive leadership experience from their service as
executives and/or directors of other entities. The biography of each of the nominees below contains
information regarding the persons service as a director, business experience, director positions
held currently or at any time during the last five years, and the specific experiences,
qualifications, attributes and skills that caused the Nominating & Corporate Governance Committee
and our Board to determine that the person should serve as a director until our 2012 annual
meeting, given our business and structure.
7
THE BOARD RECOMMENDS A VOTE FOR EACH NOMINEE. THE EIGHT NOMINEES WHO
RECEIVE THE HIGHEST NUMBER OF AFFIRMATIVE VOTES WILL BE ELECTED AS
DIRECTORS.
Peter J. Boni, age 65, joined Safeguard as President and Chief Executive Officer and a member of
the Board in August 2005. Mr. Boni previously served as a director of Clarient, Inc. and was
previously non-executive Chairman of Intralinks, Inc. Positions held include Operating Partner for
Advent International, Inc., a global private equity firm with $10 billion under management (April
2004 to August 2005); Chairman and Chief Executive Officer of
Surebridge, Inc., an applications outsourcer serving the mid-market (March 2002 to April 2004);
Managing Principal of Vested Interest LLC, a management consulting firm (January 2001 to March
2002); and President and Chief Executive Officer of Prime Response, Inc., an enterprise
applications software provider (February 1999 to January 2001). Mr. Boni holds a BA degree from
the University of Massachusetts at Amherst and has more than 25 years of experience in venture
capital/private equity; capital markets transactions; debt and equity financings; strategic
planning and development; merger and acquisition transactions; and domain expertise in the
technology sector.
Julie A. Dobson, age 54, has served on our Board since 2003. Ms. Dobson also is a director of
American Water Works Company, Inc. and PNM Resources, Inc. and previously served as non-executive
Chairperson of the Board of LCC International, Inc. Positions held include Chief Operating
Officer (1998 until February 2002) of TeleCorp PCS, Inc., a wireless/mobile phone company that was
acquired by AT&T Wireless, Inc. in late 2001; President of Bell Atlantic Corporations New York/
New Jersey Metro Region mobile phone operations (1997 to 1998); and a number of executive positions
during her 18-year career with Bell Atlantic Corporation, including sales, operations, and
strategic planning and development in the chief executive officers office. Ms. Dobson holds a BS
degree from The College of William and Mary and an MBA degree from the University of Pittsburgh.
Ms. Dobson has 22 years of corporate and entrepreneurial experience, including experience relevant
to corporate finance and accounting matters; strategic planning, corporate development and
operations management; capital markets transactions; and debt and equity financings. Ms. Dobson
also has relevant experience growing businesses organically and through merger and acquisition
transactions; and experience serving on public company boards and the principal committees thereof.
Andrew E. Lietz, age 72, has served on our Board since 2003 and was appointed Chairman of the Board
in August 2009. Mr. Lietz also is a director of Amphenol Corporation and DDi Corp. and previously
served as a director of Omtool Corporation. Positions held include Managing Director and Founder
of Rye Capital Management, LLC, a private equity investment firm (2001 to 2008); Executive Chairman
(late 2000 until mid 2002) of Clare Corporation, a designer and manufacturer of integrated
circuits, solid-state relays and electronic switches, which was acquired by Ixys Corporation in
June 2002; President and Chief Executive Officer (1995 to 2000) of, and several other executive
positions during his 16-year career with, Hadco Corporation, a global manufacturer of electronic
interconnect products and services; and a variety of positions at IBM Corporation. Mr. Lietz holds
a BS degree from the Wayne State University Business Administration School. He has more than 40
years of corporate management experience, including strategic planning; operations management;
capital markets transactions; debt and equity financings; merger and acquisition transactions; and
more than 20 years service in public sector activities and on public company boards.
George MacKenzie, age 62, has served on our Board since 2003. Mr. MacKenzie also is a director of
American Water Works Company, Inc. and Tractor Supply Company and previously served as a director
of C&D Technologies, Inc., Central Vermont Public Service Company and Traffic.com. Positions held
include non-executive Chairman of the Board (May 2006 to present) and interim Chief Executive
Officer (January 2006 to April 2006) of American Water, a provider of water services in North
America; interim Chief Executive Officer of C&D Technologies, Inc., a technology company that
produces and markets systems for the conversion and storage of electrical power (March 2005 to July
2005); Executive Vice President and Chief Financial Officer of P.H. Glatfelter Company, a
manufacturer of specialty papers and engineered products (September 2001 to June 2002); Vice
Chairman (2000 to 2001) and Chief Financial Officer (1995 until his retirement in 2001) of, and
several other executive positions during his 22-year career with, Hercules, Incorporated, a global
chemical specialties manufacturer. Mr. MacKenzie holds a BS degree from the University of Delaware
and an MBA degree from the University of Chicago. Mr. MacKenzie has extensive experience in
corporate finance and accounting. He has served as the chief financial officer of a publicly
traded company, and he is a certified public accountant. Mr. MacKenzie also has experience in
capital markets transactions; debt and equity financings; global strategic planning and operations
management; merger and acquisition transactions; and risk management. In addition, he has
extensive public company board experience, including service on multiple audit, compensation and
nominating and corporate governance committees.
8
George D. McClelland, age 64, has served on our Board since 2006. Positions held include
co-founder, Vice Chairman and Director of Business Development of F Squared Investments, an
investment management company (2006 to present); Chairman, CEO and co-founder of eSecLending, a
provider of securities lending services to the pension
industry (2000 to 2001); a director of Riverstone Networks, Inc. and Storage Networks, Inc.; Senior
Vice President, responsible for managing many of the portfolio companies of United Asset Management
Corporation, a public holding company (1994 to 2001); multiple corporate management roles at FMR
Corp., a diversified financial services company (1987 to 1991); and Corporate Treasurer of Data
General Corporation, a technology company (1972 to 1987). Mr. McClelland holds a BA degree from
Trinity College and an MBA degree from Harvard Business School. Mr. McClelland has extensive
experience in corporate finance, treasury and accounting; capital markets transactions; debt and
equity financings; venture investment; investment management; merger and acquisition transactions;
and risk management. He also has entrepreneurial experience as a founding member of multiple
companies; extensive domain expertise in the technology, healthcare and financial sectors; and
public and private company board service experience.
Jack L. Messman, age 71, has served on our Board since 1994. Mr. Messman also is a director of AMG
Advanced Metallurgical Group N.V., RadioShack Corporation and Timminco Limited. Positions held
include Chairman of the Board and Chief Executive Officer of Novell, Inc., a provider of
infrastructure software products focused around Linux and identity management (2001 to 2006); Chief
Executive Officer and President of Cambridge Technology Partners (Massachusetts), Inc., an
e-business systems integration company (August 1999 until its acquisition by Novell, Inc. in July
2001); Chairman and Chief Executive Officer of Union Pacific Resources Group Inc., an independent
oil and gas exploration and production company (April 1991 to August 1999); and Chairman and Chief
Executive Officer of USPCI, Inc., Union Pacifics environmental services company (May 1988 to April
1991). Mr. Messman holds a BS degree from the University of Delaware and an MBA degree from
Harvard Business School. Mr. Messman has extensive experience in treasury and financial planning
matters; capital markets transactions; debt and equity financings; strategic planning and
operations management; and merger and acquisition transactions. In addition, he possesses domain
expertise in the technology sector and public and private company board service experience.
John J. Roberts, age 66, has served on our Board since 2003. Mr. Roberts also is a director of
Armstrong World Industries, Inc. and Vonage Holdings Corp. and a trustee of Pennsylvania Real
Estate Investment Trust and previously served as a director of Sicor, Inc. Positions held include
Global Managing Partner and a Member of the Leadership Team of PricewaterhouseCoopers LLP at the
time of his retirement in June 2002, completing a 35-year career with the professional services
firm during which he served in a variety of client service and operating positions. Mr. Roberts
holds a BSBA degree from Drexel University and is a certified public accountant. Mr. Roberts has
extensive experience in corporate finance and accounting; capital markets transactions; debt and
equity financings; global strategic planning, corporate development and operations management;
management and technology consulting; risk management; and merger and acquisition transactions. He
also has public company board service experience, including service on multiple audit committees.
Dr. Robert J. Rosenthal, age 54, has served on our Board since 2007. Dr. Rosenthal also is a
director of Primera Dx. Positions held include Chairman of the Board and Chief Executive Officer
of IMI Intelligent Medical Implants AG, a company that is developing an intelligent retinal implant
system for degenerative retinal disorders (January 2010 to present); President, Chief Executive
Officer and a director of Magellan Biosciences, Inc., a provider of clinical diagnostics and life
sciences research tools (October 2005 to December 2009); President, Chief Executive Officer and a
director of TekCel, Ltd., a provider of life sciences research tools (October 2003 to January
2007); President and Chief Executive Officer of Boston Life Sciences, Inc., a diagnostic and
therapeutic development company (July 2002 to October 2003); President and Chief Executive Officer
of Magellan Discovery Technologies, LLC, a life sciences acquisition company (January 2001 to July
2002); Senior Vice President of PerkinElmer Corporation and President of its instrument division
(March 1999 to November 2000); and in various executive positions at Thermo Optek Corporation
(September 1995 to February 1999). Dr. Rosenthal holds a BS degree from the University of
Maryland, an MS degree from State University of New York, and a PhD degree from Emory University;
completed a post-doctoral fellowship at, and was a guest scientist of the Alexander von Humboldt
Foundation, followed by an additional post-doctoral fellowship at UCLA; and he holds an AEA
Executive MBA degree from Stanford University. Dr. Rosenthal has 20 years of experience relating
to companies involved in the development of diagnostics, therapeutics, medical devices, and life
sciences tools. His specific experience includes strategic planning and positioning; corporate and
product development; operations management; capital markets transactions; debt and equity
financings; fund-raising; merger and acquisition transactions; and corporate finance. Dr.
Rosenthal also has significant public and private company board experience.
9
CORPORATE GOVERNANCE AND BOARD MATTERS
Safeguards Corporate Governance Guidelines and Code of Business Conduct and Ethics, and the
charters for the Boards Audit Committee, Compensation Committee and Nominating & Corporate
Governance Committee, are available at www.safeguard.com/governance. The Code of Business Conduct
and Ethics is applicable to all employees of Safeguard, including each of our executive and
financial officers, and the members of our Board. Safeguard intends to post information regarding
amendments to or waivers from our Code of Business Conduct and Ethics (to the extent applicable to
Safeguards directors or executive officers) in the Corporate Governance section of our website.
Our website is not part of this proxy statement. All references to our website address are
intended to be inactive textual references only.
Board Independence. Safeguards common stock is listed on the NYSE. To assist the Board in making
independence determinations, the Board has adopted categorical standards which are reflected in our
Corporate Governance Guidelines. Generally, under these standards, a director does not qualify as
an independent director if any of the following relationships exist:
|
|
Currently or within the previous three years, the director has been employed by us; someone
in the directors immediate family has been one of our executive officers; or the director or
someone in the directors immediate family has been employed as an executive officer of
another company where any of our present executive officers at the same time serves or served
on that companys compensation committee; |
|
|
The director is a current partner or employee, or someone in the directors immediate
family is a current partner of, a firm that is our internal or external auditor; someone in
the directors immediate family is a current employee of the firm and personally works on our
audit; or the director or someone in the directors immediate family is a former partner or
employee of such a firm and personally worked on our audit within the last three years; |
|
|
The director or someone in the directors immediate family received, during any 12-month
period within the last three years, more than $120,000 in direct compensation from us (other
than director and committee fees and pension or other forms of deferred compensation for prior
service that are not contingent in any way on continued service); |
|
|
The director is a current employee or holder of more than 10% of the equity of another
company, or someone in the directors immediate family is a current executive officer or
holder of more than 10% of the equity of another company, that has made payments to or
received payments from us, in any of the last three fiscal years of the other company, that
exceeds the greater of $1 million or 2% of such other companys consolidated gross revenues;
or |
|
|
The director is a current executive officer of a charitable organization to which we have
made charitable contributions in any of the charitable organizations last three fiscal years
that exceed the greater of $1 million or 2% of that charitable organizations consolidated
gross revenues. |
The Board has determined that Julie Dobson, Andrew Lietz, George MacKenzie, George McClelland, Jack
Messman, John Roberts and Robert Rosenthal have no direct or indirect material relationships with
us other than their directorship and, therefore, are independent within the meaning of the NYSE
listing standards and satisfy the categorical standards contained in our Corporate Governance
Guidelines. Mr. Boni, our Chief Executive Officer, is our only non-independent director.
Board Leadership Structure and Committee Composition. At the date of this proxy statement,
Safeguards Board has eight members and four standing committees. The Board held seven meetings in
2010. Each incumbent director attended at least 75% of the total number of meetings of the Board
and committee(s) of which he or she was a member. Directors are invited and encouraged to attend
annual meetings of Safeguard shareholders. Safeguard typically undertakes to schedule its annual
meeting for a date, time and place that is coordinated with a normally scheduled Board meeting so
as to encourage attendance at the annual meeting by all directors. Seven of our directors attended
our 2010 annual meeting of shareholders.
10
Based upon the recommendation of our Nominating & Corporate Governance Committee, the Board has
determined that separating the roles of the Chief Executive Officer and Chairman of the Board is in
the best interests of the
shareholders at the present time. The Board views the role of the Chief Executive Officer as
having responsibility for the day-to-day leadership and performance of Safeguard, while the
Chairman of the Board provides guidance to the Chief Executive Officer, sets the agenda for Board
meetings and presides over meetings of the Board.
Under our Corporate Governance Guidelines and NYSE listing standards, non-employee directors meet
in executive session at each regularly scheduled Board meeting, outside of the presence of any
management directors and any other members of Safeguards management. The Chairman presides at
these sessions.
The table below describes the membership of each of the current committees during 2010 and the
number of meetings held by each of these committees during 2010.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nominating & |
|
|
Acquisition |
|
Audit |
|
Compensation |
|
Corporate Governance |
Number of Meetings held in 2010 |
|
4 |
|
5 |
|
6 |
|
2 |
Membership: |
|
|
|
|
|
|
|
|
Peter J. Boni |
|
√
|
|
|
|
|
|
|
Michael J. Cody (1) |
|
|
|
|
|
|
|
|
Julie A. Dobson (2) |
|
|
|
|
|
Chairperson |
|
√ |
Andrew E. Lietz (2) |
|
√ |
|
|
|
√ |
|
|
George MacKenzie |
|
|
|
Chairperson |
|
|
|
|
George D. McClelland |
|
|
|
√ |
|
√ |
|
Chairperson |
Jack L. Messman |
|
√ |
|
|
|
|
|
√ |
John J. Roberts |
|
|
|
√ |
|
√ |
|
|
Robert J. Rosenthal |
|
Chairperson |
|
√ |
|
|
|
|
|
|
|
|
|
Denotes former committee member. |
|
(1) |
|
Mr. Cody, a former Safeguard director, served on these committees until May 2010. |
|
(2) |
|
In May 2010, Ms. Dobson joined the Nominating & Corporate Governance Committee and Mr. Lietz
joined the Acquisition Committee. |
Based on the recommendation of our Nominating & Corporate Governance Committee, our Board has
determined that our current committee structure is the most appropriate for Safeguard, at present.
Acquisition Committee. As described in detail in its charter, the Board has delegated to the
Acquisition Committee the authority to approve, between regularly scheduled Board meetings, the
following transactions:
|
|
Follow-on transactions in existing partner companies involving amounts between $5 million
and $20 million; |
|
|
New transactions involving amounts between $10 million and $20 million; and |
|
|
Divestitures of existing partner companies involving amounts between $10 million and $20
million. |
Audit Committee. The Audit Committees responsibilities, which are described in detail in its
charter, include, among other duties, the responsibility to:
|
|
Assist the Board in fulfilling its responsibilities regarding general oversight of the
integrity of Safeguards financial statements, Safeguards compliance with legal and
regulatory requirements, and the performance of Safeguards internal audit function; |
|
|
Interact with and evaluate the performance, qualifications and independence of Safeguards
independent registered public accounting firm; |
|
|
Review and approve related party transactions; and |
|
|
Prepare the report required by SEC regulations to be included in the proxy statement. |
11
The Audit Committee has the sole authority to retain, set compensation and retention terms for,
terminate and oversee the relationship with Safeguards independent registered public accounting
firm (which reports directly to the Audit Committee). The Audit Committee also oversees the
activities of the internal auditor, reviews the effectiveness of the internal audit function and
approves the appointment of the internal auditor. The Audit
Committee has the authority to obtain advice, counsel and assistance from internal and external
legal, accounting or other advisors as the Audit Committee deems necessary to carry out its duties
and to receive appropriate funding from Safeguard for such advice and assistance. The full
responsibilities of the Audit Committee are set forth in the Audit Committee Charter, which is
reviewed annually by the Committee. The Audit Committee Charter is available through the Corporate
Governance link on our website at www.safeguard.com/governance.
The Board has determined that each member of the Audit Committee meets the independence
requirements established by SEC regulations, the NYSE listing standards and by our Corporate
Governance Guidelines. The Board has determined that Messrs. MacKenzie, McClelland and Roberts and
Dr. Rosenthal are audit committee financial experts within the meaning of the SEC regulations,
and the Board has determined that each member of the Audit Committee has accounting and related
financial management expertise within the meaning of the NYSE listing standards. Mr. Roberts
serves as a member of the audit committee of the board of directors of four publicly traded
companies, including our Audit Committee. The Board has determined that such simultaneous service
does not impair Mr. Roberts ability to effectively serve on our Audit Committee.
Compensation Committee. The Compensation Committees responsibilities, which are described in
detail in its charter, include, among other duties, the responsibility to:
|
|
Approve the philosophy for compensation of our executives and other employees; |
|
|
Establish compensation (including base salary, incentive compensation and equity-based
programs) for our Chief Executive Officer and other executive officers; |
|
|
Administer the long- and short-term compensation and performance-based incentive plans
(which are cash and equity based); |
|
|
Approve employment agreements and perquisites provided to our executive officers; |
|
|
Review managements recommendations for our broad-based employee benefit plans; |
|
|
Evaluate and recommend to the Board the compensation for all non-employee directors for
service on the Board and its committees; and |
|
|
Review and discuss with management the Compensation Discussion and Analysis and recommend
to the Board its inclusion in our Form 10-K and proxy statement. |
It also is the responsibility of the Compensation Committee to assess Safeguards compensation
policies and practices insofar as they may create risk for Safeguard. The Compensation Committee
constantly takes into account how the policies and practices that it utilizes may affect Safeguard.
In early 2010, the Committee specifically undertook to assess the potential effect of Safeguards
compensation policies and practices on the Company and made the affirmative determination that the
committee does not believe that any of our compensation policies and practices are reasonably
likely to have a material adverse effect on Safeguard. It should be noted that Safeguards Audit
Committee and our Board have concurred in that determination.
The Compensation Committee Charter is available through the Corporate Governance link on our
website at www.safeguard.com/governance. The Board has determined that each member of the
Compensation Committee meets the independence requirements established in the NYSE listing
standards and by our Corporate Governance Guidelines.
A discussion of some of the Compensation Committees processes and procedures for the consideration
and determination of executive compensation is contained in Compensation Discussion and
AnalysisSetting Executive Compensation. Additional processes and procedures include the
following:
|
|
Meetings. The Compensation Committee generally meets at least four times each year, with
additional meetings being scheduled as needed. The annual committee calendar is established
prior to the beginning of each year, and agendas for each meeting are established in
consultation with the Compensation Committee Chairperson. The Compensation Committee meets in
executive session during or prior to the end of each regularly scheduled meeting. |
12
|
|
Role of Consultant. The Committee has retained Semler Brossy Consulting Group, LLC to
assist the Compensation Committee in its deliberations regarding executive and director
compensation. Specifically, the Compensation Committees consultants provide the Committee
with information relating to competitiveness of pay levels, compensation design, market trends
and technical considerations concerning both executives and directors, and assist the
Compensation Committee with the reporting of executive compensation under the SECs proxy
disclosure rules. These services, which are provided in support of decision-making by the
Compensation Committee, are the only formal services that the compensation consultant performs
for Safeguard. From time to time since its hire, Semler Brossy also has provided
miscellaneous data and research to the Compensation Committee relating to various compensation
topics generally. The consultant reports to and acts at the direction of, and attends
selected meetings as requested by, the Chairperson of the Compensation Committee. The
Compensation Committee has the sole authority to hire and terminate consultants and evaluates
the performance of its consultant(s) annually. |
|
|
Role of Executive Team. Our Chief Executive Officer, Chief Financial Officer and General
Counsel, with the assistance of other company employees as they request, provide support to
the Compensation Committee by preparing materials to assist the Committee in making its
compensation decisions; conferring with the Committee and its consultant on the selection of
peer companies and industries used for comparison purposes; providing suggestions to the
Committee in the area of executive compensation, including suggestions in the context of terms
of employment agreements, performance measures and targets under our management incentive
plan, and equity awards; and ultimately implementing the Committees compensation decisions.
Management also provides the Compensation Committee with comprehensive tally sheets on an
annual basis to facilitate the Committees review of the total compensation of our named
executive officers and other executives. The tally sheets include both historical data and
estimated forward looking amounts for the current calendar year. The tally sheets summarize:
cash compensation (salary, actual/target cash incentive awards and perquisites); the dollar
value of benefits provided; potential severance amounts payable under various scenarios; and
outstanding equity awards held by each named executive officer and other executives. The
Compensation Committee discusses its compensation views with the Chief Executive Officer, and
the Chief Executive Officer makes recommendations to the Compensation Committee for salary
adjustments and equity and non-equity plan participation and awards to the named executive
officers and other executives. However, other than for compensation that has been established
contractually or under quantitative formulas established by the Compensation Committee each
year under our management incentive plan, the Compensation Committee exercises its own
discretion in determining additional compensation, which may take the form of cash or equity,
for the named executive officers and other executives. Additional information can be found in
Compensation Discussion and AnalysisRole of Named Executive Officers in Compensation
Decisions. |
Nominating & Corporate Governance Committee. The Nominating & Corporate Governance Committees
responsibilities, which are described in detail in its charter, include, among other duties, the
responsibility to:
|
|
Establish criteria for the selection of directors; |
|
|
Evaluate and consider qualified Board candidates, including those recommended by
shareholders; |
|
|
Recommend to the Board the nominees for director, including nominees for director in
connection with Safeguards annual meeting of shareholders; |
|
|
Conduct an annual evaluation of the Board and its members and oversee the evaluations of
each of the Board committees; |
|
|
Take a leadership role in shaping Safeguards corporate governance policies, including
developing and recommending to the Board Safeguards Corporate Governance Guidelines and Code
of Business Conduct and Ethics; |
|
|
Review with management Safeguards strategic direction and Safeguards strategic plan and
the implementation of managements long-term strategy and to report to the Board on such
activities; |
|
|
Evaluate the performance of the Chief Executive Officer; and |
|
|
Monitor the process of succession planning for the Chief Executive Officer and executive
management. |
13
The Nominating & Corporate Governance Committee Charter is available through the Corporate
Governance link on our website at www.safeguard.com/governance. The Board has determined that each
member of the committee meets the independence requirements established in the NYSE listing
standards and by our Corporate Governance Guidelines.
The Nominating & Corporate Governance Committee may use any number of methods to identify potential
nominees, including personal, management and industry contacts; recruiting firms; and, as described
below under the heading Process for Submission of Shareholder Recommendations for Board Nominees,
candidates recommended by shareholders.
Annual Performance Evaluations. The directors and Nominating & Corporate Governance Committee
annually assess the performance of the Board based on input from all directors. The Audit
Committee, Compensation Committee and Nominating & Corporate Governance Committee also annually
assess their respective performance and committee processes.
Review and Approval of Transactions with Related Persons. The Board has adopted a written policy
which charges the Audit Committee with the responsibility of reviewing with management at each
regularly scheduled meeting and determining whether to approve any transaction (other than a
transaction that is available to all employees generally on a non-discriminatory basis) between us
and our directors, director nominees and executive officers or their immediate family members.
Between regularly scheduled meetings of the Audit Committee, management may preliminarily approve a
related party transaction, subject to ratification of the transaction by the Audit Committee. If
the Audit Committee does not ratify the transaction, management will make all reasonable efforts to
cancel the transaction.
Risk Management. Our Board, as a whole and at the committee level, is actively involved in the
oversight of risks that affect Safeguards business. The Compensation Committee is responsible for
overseeing the management of risks relating to our compensation plans and arrangements. The Audit
Committee oversees the management of financial related risks and related party transactions. The
Nominating & Corporate Governance Committee manages risks associated with the independence of our
Board and potential conflicts of interest. Although the oversight of certain risks is conducted
through committees of the Board, our full Board retains responsibility for risk oversight and no
individual committee has been delegated responsibility for such function. Our Board receives
reports at each regularly scheduled Board meeting by each committee chair regarding each
committees considerations and actions, as well as regular reports directly from our senior
management team regarding particular risks that may impact Safeguard. This allows our Board and
its committees to coordinate the risk oversight role and to keep our Board timely apprised of all
risks that might impact Safeguards business.
Communications with Safeguards Board and Audit Committee. Any shareholder or other interested
party may communicate with our Board or any specified non-management director(s) by addressing the
communication as follows:
c/o Secretary
Safeguard Scientifics, Inc.
435 Devon Park Drive, Building 800
Wayne, PA 19087-1945
All communications are initially reviewed by our Secretary. The Chairperson of the Audit Committee
is advised promptly of any communication that alleges misconduct on the part of Safeguards
management or raises legal, ethical or compliance concerns about Safeguards policies or practices.
Safeguards Audit Committee also has established procedures for confidential, anonymous submission
of complaints by employees and for receipt, retention and treatment of complaints, from whatever
source, received by Safeguard, regarding accounting, internal accounting controls or auditing
matters. All such communications are initially sent to the Chairperson of the Audit Committee and,
if requested by the Chairperson, may be sent to the other members of the Audit Committee. Any
person who desires to contact the Audit Committee may do so by addressing correspondence to
Chairperson, Audit Committee, care of our Secretary at the address noted above.
14
The Chairperson of the Audit Committee also receives updates on other communications to the Board,
Audit Committee or non-employee directors that raise issues related to the affairs of Safeguard but
which do not fall into the two prior categories. The Chairperson of the Audit Committee determines
which of these communications he would like to see.
Our Secretary maintains a log of all communications, which is available for review upon request of
any member of the Board. Typically, we do not forward to our non-management directors
communications from our shareholders or other communications which are of a personal nature or not
related to the duties and responsibilities of the Board, including, without limitation, business
plan or other business opportunity submissions; inquiries related to products or services provided
by Safeguards companies; spam, junk mail and mass mailings; resumes and other forms of job
inquiries; surveys or polls; business solicitations or advertisements; and any material that
relates to improper or irrelevant topics or is unduly hostile, threatening, illegal or similarly
unsuitable.
Process for Submission of Shareholder Recommendations for Board Nominees. In considering
candidates, the Nominating & Corporate Governance Committee seeks the following attributes for
director nominees:
|
|
A strong record of personal integrity and ethical conduct; |
|
|
A leader in the companies or institutions with which he or she is affiliated; |
|
|
Competencies, skills and experiences that are complementary to the background and
experience represented on Safeguards Board and that meet the needs of Safeguards strategy
and business; |
|
|
A willingness and ability to devote sufficient time to fulfill his or her responsibilities
to Safeguard and our shareholders; |
|
|
The ability to represent the long-term interests of our shareholders; and |
|
|
The ability to provide relevant advice and counsel to management and best perpetuate the
success of Safeguards business. |
The Nominating & Corporate Governance Committee considers properly submitted shareholder
recommendations of director candidates in substantially the same manner as it considers director
candidate recommendations from other sources. Any shareholder recommendation must include the
following: the nominees name and the information about the nominee that would be required in a
proxy statement under the SECs rules; information about the relationship between the nominee and
the nominating shareholder; proof of the number of shares of Safeguard common stock that the
nominating shareholder owns and the length of time the shares of Safeguard common stock have been
owned; and a letter from the nominee certifying his or her willingness to serve, if elected, as a
director.
Recommendations should be directed to:
Chairperson, Nominating & Corporate Governance Committee
c/o Secretary
Safeguard Scientifics, Inc.
435 Devon Park Drive, Building 800
Wayne, PA 19087-1945
15
Board Compensation. Effective as of May 2010, each of our non-employee directors was compensated
for his or her service as a director through cash payments as shown in the table below:
|
|
|
|
|
Compensation Item |
|
Amount |
|
Annual Board Retainers (payable relative to a full year of
Board service measured from annual meeting to annual
meeting): |
|
|
|
|
Chairman of the Board |
|
$ |
80,000 |
|
Other Directors |
|
|
50,000 |
|
Additional Annual Chairperson Retainers (payable relative to
a full year of Committee service measured from annual meeting
to annual meeting): |
|
|
|
|
Acquisition Committee |
|
|
5,000 |
|
Audit Committee |
|
|
15,000 |
|
Compensation Committee |
|
|
7,500 |
|
Nominating & Corporate Governance Committee |
|
|
5,000 |
|
Meeting Attendance Fees: |
|
|
|
|
Committee |
|
|
1,500 |
|
We also reimburse our directors for expenses they incur to attend our Board and Committee meetings
and for attendance at one directors continuing education program during each calendar year or the
reasonable cost of one years membership in an organization which is focused on director education
On May 13, 2010, following our 2010 annual meeting, each director also was awarded a recurring
annual service grant which consisted of a stock option grant to purchase 5,000 shares of Safeguard
common stock at an exercise price of $12.2938 per share and 2,500 deferred stock units, as more
fully described below. Directors stock options have an eight-year term. Annual service stock
option and deferred stock unit grants fully vest on the first anniversary of the grant date or, for
deferred stock units, once a director reaches age 65, if earlier. The exercise price of stock
options is equal to the average of the high and low trading prices of our common stock, as reported
on the NYSE composite tape, on the grant date. The deferred stock units represent the right to
receive shares of Safeguard common stock, on a one-for-one basis, on or about the first anniversary
of the date upon which the director leaves the Board.
Safeguard also maintains a Group Deferred Stock Unit Program for Directors (Directors DSU
Program) which allows each director, at his or her election, to receive deferred stock units in
lieu of cash retainer and meeting fees paid to each director, as described above, for service on
the Board and its committees (Directors Fees). The deferral election applies to Directors Fees
to be received for the calendar year following the year in which the election is made and remains
in effect for each subsequent year unless the director elects otherwise by the end of the calendar
year prior to the year in which the services are rendered. The number of deferred stock units
awarded is determined by dividing the Directors Fees by the fair market value of Safeguards stock
on the date on which the director would have otherwise received the Directors Fees. Each director
also receives a number of matching share units, based on the same fair market value calculation,
equal to 25% of the Directors Fees deferred. A director is always fully vested in Directors Fees
deferred; the matching share units vest fully on the first anniversary of the date the matching
share units are credited to the directors account or, if earlier, once a director reaches age 65.
Each deferred stock unit entitles the director to receive one share of Safeguard common stock on or
about the first anniversary of the date upon which the director leaves the Board. A director also
may elect to receive the stock in annual installments over a period of up to five years after
leaving the Board.
16
Director Compensation 2010. The following table provides information on compensation earned for
services provided during 2010 by each non-employee director who served on our Board at any time
during 2010:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fees Earned or |
|
|
Stock |
|
|
Option |
|
|
All Other |
|
|
|
|
|
|
Paid in Cash |
|
|
Awards |
|
|
Awards |
|
|
Compensation |
|
|
Total |
|
Name |
|
($)(1) |
|
|
($)(2)(3) |
|
|
($)(3)(4) |
|
|
($)(5) |
|
|
($)(6) |
|
Michael J. Cody (7) |
|
$ |
23,288 |
|
|
$ |
2,018 |
|
|
$ |
|
|
|
$ |
1,200 |
|
|
$ |
26,506 |
|
Julie A. Dobson |
|
|
65,019 |
|
|
|
34,590 |
|
|
|
31,536 |
|
|
|
|
|
|
|
131,145 |
|
Andrew E. Lietz |
|
|
83,538 |
|
|
|
35,513 |
|
|
|
31,536 |
|
|
|
|
|
|
|
150,587 |
|
George MacKenzie |
|
|
71,019 |
|
|
|
31,731 |
|
|
|
31,536 |
|
|
|
|
|
|
|
134,286 |
|
George D. McClelland |
|
|
71,519 |
|
|
|
35,086 |
|
|
|
31,536 |
|
|
|
|
|
|
|
138,141 |
|
Jack L. Messman |
|
|
57,519 |
|
|
|
44,310 |
|
|
|
31,536 |
|
|
|
|
|
|
|
133,365 |
|
John J. Roberts |
|
|
61,519 |
|
|
|
34,462 |
|
|
|
31,536 |
|
|
|
|
|
|
|
127,517 |
|
Robert J. Rosenthal |
|
|
65,192 |
|
|
|
33,353 |
|
|
|
31,536 |
|
|
|
1,200 |
|
|
|
131,281 |
|
|
|
|
(1) |
|
The amounts included in this column reflect Directors Fees earned for services provided
during 2010, including amounts deferred under our Directors DSU Program. Of the amount of
Directors Fees earned for services provided during 2010, Mr. Messman deferred payment of
100%, Dr. Rosenthal deferred payment of 15%, and Ms. Dobson and Messrs. Lietz, McClelland and
Roberts each deferred payment of 25%. Each director received deferred stock units in lieu of
Directors Fees that they deferred and matching deferred stock units equal to 25% of the
Directors Fees that they deferred. Directors who defer fees and receive deferred stock units
are essentially investing in common stock equivalents that are initially valued based on the
fair market value of our common stock on the date of issuance. As a result, the value of
their deferred stock units fluctuates with the market value of our common stock. For Mr.
Cody, the amount reported includes $3,500 paid to him for attending meetings as Safeguards
designated member on the board of directors of a Safeguard partner company. |
|
(2) |
|
These amounts do not represent compensation actually received. Rather, these amounts
represent the grant date fair values of the matching deferred stock units computed in
accordance with stock-based compensation accounting rules (FASB ASC Topic 718), excluding the
effect of estimated forfeitures related to service-based vesting conditions. The fair value
of the matching deferred stock units is determined by multiplying the number of shares
underlying the matching deferred stock units by the average of the high and low trading prices
of Safeguards common stock, as reported on the NYSE composite tape, on the grant date. The
matching deferred stock units issued in January 2010 related to fees deferred that were earned
during the fourth quarter of 2009. The following table presents the grant date fair value for
each deferred stock unit award made to each non-employee director during 2010: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Grant Date Fair Value (in dollars) |
|
Name |
|
1/15/10 |
|
|
4/15/10 |
|
|
5/13/10 |
|
|
7/15/10 |
|
|
10/15/10 |
|
Michael J. Cody |
|
$ |
770 |
|
|
$ |
990 |
|
|
$ |
258 |
|
|
$ |
|
|
|
$ |
|
|
Julie A. Dobson |
|
|
974 |
|
|
|
1,101 |
|
|
|
30,735 |
|
|
|
785 |
|
|
|
995 |
|
Andrew E. Lietz |
|
|
1,098 |
|
|
|
1,213 |
|
|
|
30,735 |
|
|
|
1,036 |
|
|
|
1,431 |
|
George MacKenzie |
|
|
996 |
|
|
|
|
|
|
|
30,735 |
|
|
|
|
|
|
|
|
|
George D. McClelland |
|
|
1,121 |
|
|
|
1,338 |
|
|
|
30,735 |
|
|
|
842 |
|
|
|
1,050 |
|
Jack L. Messman |
|
|
3,441 |
|
|
|
3,931 |
|
|
|
30,735 |
|
|
|
2,697 |
|
|
|
3,506 |
|
John J. Roberts |
|
|
951 |
|
|
|
1,046 |
|
|
|
30,735 |
|
|
|
762 |
|
|
|
968 |
|
Robert J. Rosenthal |
|
|
860 |
|
|
|
641 |
|
|
|
30,735 |
|
|
|
489 |
|
|
|
628 |
|
|
|
|
(3) |
|
The directors aggregate holdings of deferred stock units and stock options to purchase
shares of our common stock (both vested and unvested), as of December 31, 2010, were as
follows: |
|
|
|
|
|
|
|
|
|
|
|
Deferred Stock |
|
|
Stock |
|
Name |
|
Units |
|
|
Options |
|
Michael J. Cody |
|
|
4,166 |
|
|
|
24,997 |
|
Julie A. Dobson |
|
|
16,379 |
|
|
|
30,830 |
|
Andrew E. Lietz |
|
|
10,697 |
|
|
|
39,163 |
|
George MacKenzie |
|
|
9,696 |
|
|
|
37,413 |
|
George D. McClelland |
|
|
39,944 |
|
|
|
29,997 |
|
Jack L. Messman |
|
|
36,936 |
|
|
|
30,830 |
|
John J. Roberts |
|
|
15,076 |
|
|
|
39,163 |
|
Robert J. Rosenthal |
|
|
10,149 |
|
|
|
21,665 |
|
Under the terms of the Directors DSU Program, since the deferred stock units held by Mr. Cody
relating to Directors Fees which he deferred had a value of less than $50,000, he received a
distribution of 3,043 shares underlying his deferred stock units upon his termination of Board
service. The shares underlying his deferred stock units which remained outstanding at December
31, 2010 will be distributed in May 2011.
17
|
|
|
(4) |
|
These amounts do not represent compensation actually received. Rather, these amounts
represent the grant date fair values of the stock options computed in accordance with
stock-based compensation accounting rules (FASB ASC Topic 718), excluding the effect of
estimated forfeitures related to service-based vesting conditions. The fair value of the
stock options awarded to each director on May 13, 2010, was estimated at the date of grant
using the Black-Scholes option-pricing model. The assumptions used by us in calculating these
amounts are incorporated by reference to Note 10 to our Consolidated Financial Statements in
our Annual Report on Form 10-K for the fiscal year ended December 31, 2010. |
|
(5) |
|
The amounts in this column represent reimbursement of expenses incurred by these directors
for attendance at a directors continuing education program or a directors reasonable 2010
annual dues for a membership organization focused on director education. |
|
(6) |
|
Directors also are eligible for reimbursement of expenses incurred in connection with
attendance at Board and committee meetings. These amounts are not included in the table
above. |
|
(7) |
|
Mr. Cody served as a director until May 2010. |
Stock Ownership Guidelines. Our stock ownership guidelines provide that within five years after
December 31, 2005 (for directors who served on our Board at that date) or by the end of the fifth
full calendar year after joining our Board, each non-employee director should attain an equity
position in our common stock equal to two times the annual cash Board retainer. Shares counted
toward these guidelines include:
|
|
Shares beneficially owned by the director; |
|
|
Vested shares of restricted stock; |
|
|
Vested deferred stock units that have been credited to the director; and |
|
|
Shares underlying vested, in-the-money options. |
At December 31, 2010, each non-employee director had achieved this ownership goal.
18
PROPOSAL TO RATIFY KPMG LLP
Item 2 on Proxy Card
The Audit Committee, composed entirely of independent, non-employee members of the Board, approved
the appointment of KPMG LLP (KPMG) as Safeguards independent registered public accounting firm
for the 2011 fiscal year, and the Board has recommended that our shareholders ratify the
appointment. If the shareholders do not ratify the appointment, the Audit Committee may reconsider
its recommendation and may retain KPMG or another accounting firm without resubmitting the matter
to shareholders. Even if the shareholders ratify the appointment of KPMG, the Audit Committee may
select another firm if it determines such selection to be in the best interest of Safeguard and its
shareholders.
Services provided to Safeguard and its subsidiaries by KPMG in fiscal 2010 and fiscal 2009 are
described below under Independent Registered Public Accounting FirmAudit Fees. Representatives
of KPMG are expected to attend the annual meeting. They will have an opportunity to make a
statement if they desire to do so and will be available to respond to appropriate questions.
Ratification requires the affirmative vote of a majority of the votes cast by all shareholders
entitled to vote on the proposal.
THE BOARD RECOMMENDS THAT SHAREHOLDERS VOTE FOR THE PROPOSAL TO RATIFY
KPMG AS SAFEGUARDS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
FOR THE 2011 FISCAL YEAR.
Independent Registered Public Accounting FirmAudit Fees
The following table presents fees for professional services rendered by KPMG LLP for the audit of
Safeguards consolidated financial statements for fiscal 2010 and fiscal 2009 and fees billed for
audit-related services, tax services and all other services rendered by KPMG for fiscal 2010 and
fiscal 2009. This table includes fees billed to Safeguards consolidated subsidiaries for services
rendered by KPMG.
|
|
|
|
|
|
|
|
|
|
|
2010 |
|
|
2009 (1) |
|
Audit Fees (2) |
|
$ |
460,000 |
|
|
$ |
519,117 |
|
Tax Fees (3) |
|
|
88,500 |
|
|
|
213,700 |
|
All Other Fees |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
548,500 |
|
|
$ |
732,817 |
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Includes fees billed to Clarient, Inc. through June 30, 2009. |
|
(2) |
|
Audit fees include the aggregate fees for professional services rendered in connection with
the audit of the consolidated financial statements included in our Annual Report on Form
10-K, the review of the condensed consolidated financial statements included in our Quarterly
Reports on Form 10-Q, consents and other services related to SEC and other regulatory
filings, and KPMGs assurance services provided in connection with the assessment and testing
of internal controls over financial reporting pursuant to Section 404 of the Sarbanes Oxley
Act of 2002. |
|
(3) |
|
Tax fees include the aggregate fees billed by KPMG for tax consultation and tax compliance
services. |
The Audit Committee pre-approves each service to be performed by KPMG at its regularly scheduled
meetings. For any service that may require pre-approval between regularly scheduled meetings, the
Audit Committee has delegated to the Chairperson of the Audit Committee the authority to
pre-approve services not prohibited by law to be performed by Safeguards independent registered
public accounting firm and associated fees up to a maximum for non-audit services of $100,000, and
the Chairperson communicates such pre-approvals to the Audit Committee at its next regularly
scheduled meeting.
19
AUDIT COMMITTEE REPORT
The Audit Committee assists the Board of Directors in fulfilling its responsibilities regarding
general oversight of the integrity of Safeguards financial statements, Safeguards
compliance with legal and regulatory requirements, the performance of Safeguards internal
audit function, review and approval of related party transactions, and the performance,
qualifications and independence of Safeguards independent registered public accounting
firm.
Safeguards management has primary responsibility for the financial reporting process, including
the system of internal controls, and for preparation of Safeguards consolidated financial
statements in accordance with U.S. generally accepted accounting principles. Safeguards
independent registered public accounting firm is responsible for auditing those consolidated
financial statements and issuing opinions as to the conformity of Safeguards audited financial
statements with U.S. generally accepted accounting principles and the effectiveness of Safeguards
internal control over financial reporting based on criteria established in Internal Control
Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway
Commission.
Throughout the year, the Audit Committee regularly meets with management of Safeguard, Safeguards
independent registered public accounting firm and Safeguards internal auditor. The Audit
Committee also regularly meets with each of these groups separately in closed sessions. In this
context, the Audit Committee hereby reports as follows:
|
1. |
|
The Audit Committee reviewed Safeguards audited consolidated financial statements for
fiscal year 2010 and met and held discussions with management and KPMG regarding the
audited financial statements. |
|
2. |
|
The Audit Committee discussed with KPMG the matters required to be discussed by
Statement on Auditing Standards No. 61 (AICPA, Professional Standards, Vol. 1, AU Section
380), as adopted by the Public Company Accounting Oversight Board in Rule 3200T. |
|
3. |
|
The Audit Committee received the written disclosures and the letter from KPMG required
by applicable requirements of the Public Company Accounting Oversight Board regarding the
independent accountants communications with the Audit Committee concerning independence
and discussed with KPMG its independence. |
|
4. |
|
Based on the review and discussion referred to in paragraphs 1 through 3 above, the
Audit Committee recommended to the Board that the audited consolidated financial statements
be included in Safeguards Annual Report on Form 10-K for fiscal year 2010. |
Members of the Audit Committee:
|
|
|
|
|
|
|
George MacKenzie, Chairperson
|
|
George D. McClelland
|
|
John J. Roberts
|
|
Robert J. Rosenthal |
20
NON-BINDING, ADVISORY VOTE ON EXECUTIVE COMPENSATION
Item 3 on Proxy Card
Pursuant to the proxy rules under the Securities Exchange Act of 1934, as amended (Exchange Act)
and as required by the recently enacted Dodd-Frank Act, Safeguard is required to provide its
shareholders with a non-binding, advisory vote to approve the compensation of Safeguards named
executive officers as disclosed in the Compensation Discussion and Analysis (beginning on page 23)
and the accompanying compensation tables and narrative disclosure. This proposal, commonly known
as a say-on-pay proposal, gives shareholders the opportunity to endorse or not endorse
Safeguards executive compensation as described in this proxy statement. Shareholders also may
abstain from voting. The vote is intended to provide an overall assessment of our executive
compensation program rather than focus on any specific item of compensation.
The Compensation Committee has developed an executive compensation program designed to pay for
performance and to align the long-term interests of our named executive officers with the long-term
interests of our shareholders. We are asking our shareholders to indicate their support for the
compensation afforded to our named executive officers by voting FOR the following resolution:
RESOLVED, that the compensation paid to Safeguards named executive officers, as disclosed
pursuant to the compensation disclosure rules of the Securities and Exchange Commission,
including the compensation discussion and analysis, the compensation tables and related
narrative disclosure included in this proxy statement, is hereby APPROVED.
As provided by the Dodd-Frank Act, this vote will not be binding on the Board or the Compensation
Committee and may not be construed as overruling a decision by the Board or the Compensation
Committee nor imply any additional fiduciary duty on the Board. Further, it will not affect any
compensation paid or awarded to any executive. Safeguards Board and Compensation Committee will,
however, take into account the outcome of the vote when considering future executive compensation
arrangements. The purpose of Safeguards compensation policies and procedures is to attract and
retain experienced, highly qualified executives crucial to Safeguards long-term success and
enhancement of shareholder value.
THE BOARD RECOMMENDS THAT SHAREHOLDERS VOTE FOR THE APPROVAL OF
SAFEGUARDS EXECUTIVE
COMPENSATION AS DESCRIBED IN THE COMPENSATION
DISCUSSION AND ANALYSIS AND THE ACCOMPANYING
COMPENSATION TABLES AND
NARRATIVE DISCLOSURE IN THIS PROXY STATEMENT.
21
NON-BINDING, ADVISORY VOTE CONCERNING THE FREQUENCY OF THE NON-
BINDING, ADVISORY VOTE ON EXECUTIVE COMPENSATION
Item 4 on Proxy Card
Pursuant to the proxy rules under the Exchange Act and as required by the Dodd-Frank Act, Safeguard
is required, no less frequently than once every six years, to put to shareholders a non-binding,
advisory shareholder vote concerning the frequency of future advisory votes concerning executive
compensation (Proposal 3). Safeguard shareholders may indicate whether they would prefer an
advisory vote concerning executive compensation every one (annually), two (biennially) or three
(triennially) years. Shareholders also may abstain from voting. Accordingly, Safeguard
shareholders are being asked to approve the following resolution:
RESOLVED, that the shareholders non-binding, advisory vote concerning executive
compensation shall occur every one, two, or three years, as approved by the shareholders at
the annual meeting of shareholders.
As provided by the Dodd-Frank Act, this vote will not be binding on the Board or the Compensation
Committee and may not be construed as overruling a decision by the Board or the Compensation
Committee nor imply any additional fiduciary duty on the Board. However, the Compensation
Committee and the Board recognize the importance of receiving input from Safeguards shareholders
on important issues and expect to take into account the outcome of the vote when considering the
frequency with which future say-on-pay votes will be held. So long as a quorum representing a
majority of our outstanding voting stock is present, either in person or by proxy, the affirmative
vote of a majority of the votes cast by all the shareholders entitled to vote for the proposal will
determine our shareholders preference for the frequency of advisory votes on executive compensation
in the future.
Safeguards Board is recommending an annual non-binding, advisory vote concerning executive
compensation because the Compensation Committee reviews and considers executive compensation and
Safeguards compensation policies and procedures on an annual basis. As a result, the Board
believes that input from shareholders concerning executive compensation annually, although not
binding, would be beneficial to the Compensation Committee as it considers these matters. The
accompanying form of proxy provides four choices (every one, two or three years, or abstain).
Shareholders are voting on one of these frequencies and are not voting to approve or disapprove
Safeguards recommendation.
SAFEGUARDS BOARD RECOMMENDS THAT SHAREHOLDERS VOTE FOR
AN ANNUAL NON-BINDING, ADVISORY VOTE CONCERNING EXECUTIVE COMPENSATION.
22
COMPENSATION DISCUSSION AND ANALYSIS
Overview
The Compensation Committee (for purposes of this compensation discussion and analysis, the
Committee) is responsible for establishing our company-wide compensation philosophy; for
determining the compensation provided to the individuals who serve as our Chief Executive Officer,
Chief Financial Officer and the three other individuals included in the Summary Compensation Table
(collectively referred to as the named executive officers); and for approving the compensation
for our other executives, based on recommendations of our named executive officers. Our executive
group is currently comprised of a total of 10 persons, including the named executive officers as
well as five other company employees who each hold the title of vice president or higher. The
Committee reviews our compensation philosophy each year to ensure that its principles and
objectives are aligned to our overall business strategy and aligned with the interests of our
shareholders in increasing the value of our common stock over the long term. We seek to apply a
consistent philosophy across our executive rank, not just among our named executive officers.
Compensation Philosophy and Objectives
Our overall goals in compensating our executives are to:
|
|
Attract, retain and motivate executives who are particularly qualified, as a result of
their prior professional experience, to shape our business model and pursue our business plan,
and whose experience and skills can be leveraged across our partner companies to facilitate
the partner companies growth and success; |
|
|
Promote and reward the achievement of short-term and long-term corporate and individual
objectives that our Board and management believe will lead to long-term growth in shareholder
value; and |
|
|
Encourage meaningful equity ownership and the alignment of executive and shareholder
interests as an incentive to increase shareholder value. |
The executive compensation program the Committee has created is intended to: provide an appropriate
mix of fixed and variable at-risk cash compensation; balance rewards for short-term performance
with our ultimate goal of producing long-term shareholder value; link variable compensation to
value creation; and facilitate executive recruitment and retention. There are no pre-established
targets, weighting, mix or position relative to competitors for the allocation between either cash
or non-cash compensation payments; short-term or long-term compensation; and/or fixed or variable
items of compensation. Rather, each year the Committee reviews information provided by its
consultant (as well as information which may be provided by management) to determine the
appropriate level, on an absolute and a relative basis, as well as a mix of each of these
components. It is important to highlight that more than 75% of our executives long-term
compensation is performance-based, linked directly to return to shareholders or to the
accomplishment of specific objectives which, it is believed, will result directly in share price
appreciation. Therefore, when the Committee considers the relationships between the different
components of our overall compensation philosophy, especially the relationship between fixed
compensation and long-term incentive compensation, the Committee carefully considers the
challenging performance metrics it incorporates into all of our long-term incentive compensation
programs.
23
During 2010, we used the following principal elements of executive compensation to meet our overall
goals:
|
|
|
|
|
Base Pay
|
|
à
|
|
Fixed cash compensation,
based on competitive
market practices and
existing salary levels,
that rewards an
executives core
competencies relative to
his skills, experience,
responsibilities and
anticipated contributions
to us and our partner
companies; |
|
|
|
|
|
Annual Incentives
|
|
à
|
|
Variable, at-risk,
performance-based
incentive compensation,
based on competitive
market practices and
existing incentive
compensation levels, that
rewards an executives
contributions towards the
achievement of annual
corporate objectives and
an executives achievement
of individual performance
objectives. These
incentives are paid in the
form of cash and/or equity
at the Compensation
Committees discretion; |
|
|
|
|
|
Long-Term Incentives
|
|
à
|
|
Equity awards that
encourage executive
ownership of our stock and
which promote continued
employment with us through
the use of vesting
approaches which are based
on the achievement of
milestones/results which
by their nature are
long-term and/or which are
based on extended tenure
with Safeguard. These
awards align our
executives interests with
those of our shareholders.
The value of the awards
to the executive is
directly impacted as
cash-on-cash returns on
our partner company
deployments are realized
and/or as our stock price
increases; |
|
|
|
|
|
Health and Welfare Benefits
|
|
à
|
|
Benefits that are part of
our broad-based employee
benefit programs,
including medical, dental,
life insurance, and
disability plans, our
401(k) plan matching
contributions and our
nonqualified deferred
compensation plan
(contributions to which
have been discontinued for
2009 and beyond); and |
|
|
|
|
|
Severance and Change-in-Control
Arrangements
|
|
à
|
|
Severance benefits that
are payable or which
accrue if a particular
executives employment is
terminated by Safeguard
without cause, or by the
executive for good
reason. See Potential
Payments upon Termination
or Change in Control
below. These benefits are
intended to help us retain
our named executive
officers and certain of
our other executives,
providing us with
continuity of executive
management. In the event
of a change in control, in
certain circumstances,
these severance benefits
may be increased, which
functions as a further
retention mechanism. |
Role of Named Executive Officers in Compensation Decisions
The Committee makes, or has final approval authority regarding, all compensation decisions with
respect to all of our executives. Within the parameters approved by the Committee each year, our
named executive officers are responsible for evaluating and setting compensation with respect to
our other employees.
Our Chief Executive Officer, Chief Financial Officer and General Counsel, each a named executive
officer, with the assistance of other company employees, provide support to the Committee by
preparing materials requested by the Committee to assist the Committee in making its compensation
decisions; conferring with the Committee and its consultant on the selection of peer companies and
industries used for comparison purposes; providing suggestions and, in some cases, recommendations,
to the Committee in the area of executive compensation, including suggestions in the context of
terms of employment agreements, performance measures and targets under our management incentive
plan, and equity awards; suggesting or recommending alternative approaches to certain elements of
our executive compensation philosophy; and, ultimately, implementing the Committees compensation
decisions. Management also provides the Committee with comprehensive tally sheets on an annual
basis to facilitate the Committees review of the total compensation of our named executive
officers and our other executives. The tally sheets include both historical data and estimated
forward looking amounts for the current calendar year. The tally sheets summarize: cash
compensation (salary, actual/target annual incentive awards and perquisites); the dollar value of
benefits provided; potential severance amounts payable under various scenarios; and outstanding
equity awards held by each executive.
In determining the compensation of our Chief Executive Officer, the Committee considers the results
of the CEO performance assessment conducted each year by our Nominating & Corporate Governance
Committee. The assessment includes our Chief Executive Officers self-assessment of the
achievement of his individual prior year objectives as well as an assessment of his performance by
each Board member. The Committee also discusses its compensation views with our Chief Executive
Officer directly. Neither our Chief Executive Officer nor any other
member of management is present when the Committee makes its determinations concerning our CEOs
compensation.
24
Our Chief Executive Officer annually assesses each other named executive officers performance and
makes a recommendation to the Committee concerning achievement by our other named executive
officers of their individual objectives. Our other named executive officers annually assess the
other executives who report to them and make recommendations to our Chief Executive Officer
concerning the achievement of individual objectives by such executives. Our Chief Executive Officer
makes recommendations to the Committee concerning salary adjustments and equity grants to the named
executive officers and, based on the recommendations of our other named executive officers, our
other executives. In determining the compensation of our executives, the Committee considers our
Chief Executive Officers assessment and recommendations. However, other than for compensation
that has been established contractually or under quantitative formulas established by the Committee
each year under our management incentive plan, the Committee exercises its own discretion in
determining whether to accept or modify our Chief Executive Officers recommendations. These
individuals are not present when the Committee and our Chief Executive Officer review their
performance or when the Committee makes its determinations concerning their compensation.
From time to time during the year, our Chief Executive Officer may recommend to the Committee
one-time cash bonuses, stock option or other equity grants to certain executives or other employees
relating to promotions, instances of superior individual or group performance and/or extraordinary
corporate undertakings or events. The Committee acts on such recommendations on a case-by-case
basis. During 2010, our CEO made, and the Committee acted on, one such recommendation which
resulted in the payment of one-time cash bonuses to seven of our executives, including four of our
named executive officers, one of whom is our Chief Executive Officer. Such bonuses were paid in
recognition of the role played by such executives in the sale of one of our partner companies,
Clarient, Inc., to GE Healthcare. That transaction produced net aggregate proceeds to Safeguard of
approximately $147 million. The Committee considered such accomplishment to be significant
particularly because of the premium paid by the purchaser over the public market price for
Clarients stock just prior to the announcement of the transaction; and the significant Clarient
market value increase which occurred between the time Safeguard participated in a strategic
repositioning of Clarient in 2005, and the time of the sale. It was the view of the Committee that
each of the executives who received a bonus payment played a crucial role in not only the
commercial and/or corporate development of Clarient, but also in the conclusion of the sale
transaction. The completion of this transaction had an extremely positive impact upon the market
price of our stock and the Committee rewarded the bonus recipients accordingly. It should also be
noted that matters related to Clarient were, by design, not included in the Partner Company
Performance component of the corporate objectives established under our 2010 MIP. Such one-time
bonuses totaled $725,000, in the aggregate, to our executives as a group, $175,000 of which was
paid to our Chief Executive Officer. For further detail regarding such bonuses, see the Summary
Compensation Table below.
Role of Consultant
Semler Brossy assisted the Committee in its deliberations regarding executive and director
compensation matters during 2010. Specifically, as it has in prior years, Semler Brossy provided
information relating to competitiveness of pay levels, compensation design, specific equity grant
matters, market trends, risk assessment and management and technical considerations concerning
named executive officers, other executives and directors. In addition, Semler Brossy also provided
information related to specific initiatives during the year, which initiatives included the
initiation of a clawback program. Semler Brossy also assisted the Committee with the reporting
of executive compensation matters relating to 2010 under applicable SEC disclosure rules. These
services, which were provided in support of decision-making by the Committee, are the only services
that Semler Brossy performed for Safeguard. Semler Brossy does not provide services to Safeguard
other than those provided to support the Committees activities. Semler Brossy reported to and
acted at the direction of, and attended selected meetings as requested by, the Chairperson of the
Committee.
The Committee, which has the sole authority to hire and terminate its consultant, evaluates the
performance of its consultant annually. The Committee has utilized the services of Semler Brossy
since 2008. Semler Brossy is
compensated on an hourly billing basis. Invoices are directed to, reviewed and must be approved by
the Committee Chairperson before payment by Safeguard.
25
Setting Executive Compensation
The Committee believes that a very significant portion of each executives total compensation
should be variable or at-risk. It is the view of the Committee that the greater the ability of
an executive (based on his role and responsibilities at Safeguard) to impact Safeguards
achievement of its short- and long-term objectives, the greater the percentage of such executives
overall compensation which should be at-risk. The Committee principally utilizes variable/at-risk
cash and performance-based equity compensation to accomplish its objectives in this regard. As
described below under 2010 Compensation Program Annual Incentives, the Committee provides
at-risk target bonus levels under Safeguards MIP (as defined below) to our executives. Payments
against such targets are determined by the Committee based on corporate achievement as well as
personal achievement. Payments may be made in cash and/or equity, in the Committees discretion.
Neither the actual awards to be made under the MIP or otherwise nor the minimum long-term value of
any equity grants made is guaranteed.
As described above, management provides the Committee with comprehensive tally sheets on an annual
basis to facilitate the Committees review of the total compensation of our named executive
officers and other executives. The Committee has found these tally sheets to be useful in its
evaluation of the total compensation program for our named executive officers and other executives.
From time to time, the Committee requests supplemental information be included in such tally
sheets as its discussions require.
Specifically with regard to our named executive officers, the Committee from time to time, and at
least annually, has reviewed a comparison of each element of total compensation against a group of
specific companies and industries against which we believe we compete for talent and for
shareholder investment, including the venture capital and private equity industries, as well as by
reference to industry-specific compensation surveys. The analysis provided by Semler Brossy in
December 2009 for purposes of the Committees consideration of 2010 cash and total compensation
levels measured our compensation against data from the following sources:
|
|
|
|
|
Proxy Peer Group
Data
|
|
à
|
|
Business development companies, registered investment
companies and holding companies that are representative of
the unique nature of our business model for a publicly owned
company. Included in this group were: Capital Southwest
Corporation; Harris & Harris Group, Inc.; Hercules Technology
Growth Capital, Inc.; Internet Capital Group, Inc.; Kohlberg
Capital Company; Main Street Capital Corporation; MCG Capital
Corporation and Patriot Capital Funding. |
|
|
|
|
|
Venture Capital Survey Data
|
|
à
|
|
Surveys used included the following: |
|
|
|
|
|
Dow Jones Private Equity Analyst Glocap Compensation Survey
US Mercer Benchmark Database Executive
(Each of the surveys utilized is very broad-based and,
therefore, is not highly influenced by the data relating to
any one company included in the survey.) |
The Committee annually evaluates the companies and surveys used for comparison purposes to be
certain that the comparables reviewed by the Committee remain appropriate given
mergers/acquisitions that may have occurred and any changes in relevant business scope. In
connection with the commencement of its process for its 2011 compensation review in mid 2010, the
Committee determined that reviewing compensation from multiple perspectives was still appropriate
given Safeguards unique business model. In reviewing the Proxy Peer Group in connection with that
undertaking, the Committee did decide to revise its Proxy Peer Group for compensation review
purposes by deleting Patriot Capital Funding and adding Triangle Capital Corporation, based upon
its business model. The Committee is continually refining the comparables utilized as members of
the Peer Group are acquired or merged, etc. The Committee does not focus on any one single peer or
benchmark in setting compensation levels.
Recognizing that our business strategy, industry focus and diverse array of partner companies make
comparisons to other companies difficult, and based on the inherent challenge in matching
companies, job positions and skill sets,
the Committee has looked to competitive information for general guidance rather than rigid
adherence to specific percentages. The Committee has determined that the overall objectives of our
compensation philosophy are better achieved through flexibility in determining pay levels to
address differences in duties and responsibilities, individual experience, skill levels and
achievements, and any retention concerns.
26
2010 Compensation Program
Base Pay. Base pay is established initially on the basis of several factors, including market
competitiveness; past practice; individual performance and experience; the level of responsibility
assumed; the level of skills and experience that can be leveraged across our partner companies to
facilitate their growth and success; and individual employment negotiations with executives. Each
of our named executive officers has an employment agreement with us which sets a minimum base
salary.
Base salaries typically are reviewed annually (at the end of one year and the beginning of the
upcoming calendar year) by the Committee, as well as in connection with a promotion or other
changes in job responsibilities. As noted above, Safeguard competes for executive talent with
venture capital and private equity firms, among others. In considering whether to adjust base
salary levels of any of our executives for 2010, the Committee took into account:
|
|
The proxy peer group and survey data provided by Semler Brossy; |
|
|
The Committees assessment of Safeguards overall performance during 2009 and the ongoing
individual performance of each of our named executive officers; |
|
|
United States economic conditions, in general; and |
|
|
Changes in scope of job responsibility. |
Based on the Committees review of the foregoing, the Committee determined, generally, that 2009
base salary levels for our named executive officers satisfied the Committees stated objectives for
the role of fixed cash compensation within our overall compensation philosophy and made only one
broad change to such base salary levels for 2010. The only broad change that the Committee made
was related to the elimination of perquisites, as described below.
Historically, Safeguard had included in the compensation packages for our named executive officers
certain perquisites that were paid to such executives in cash in addition to base salary. These
perquisites were as follows: car allowance (typically, $10,000), executive medical coverage
($5,000) and non-accountable expense allowance ($8,000). Based upon the recommendation of our CEO,
and on the Committees review of information provided by Semler Brossy, the Committee determined
that it would, effective January 1, 2010, eliminate the cash-settled perquisites previously
provided by Safeguard (car allowance, non-accountable expense allowance and executive medical
coverage) and increase the base salary levels of Safeguards executives in a like amount. This
resulted in an increase in base salary of $23,000 for each of the four affected named executive
officers, including our CEO.
Based upon the recommendation of our CEO, the Committee did grant an additional $18,500 base salary
increase to Kevin Kemmerer and a $23,000 base salary increase to Stephen Zarrilli, both named
executive officers, effective January 1, 2010. Mr. Kemmerers increase was made based on analysis
of competitive data; and Mr. Zarrillis increase was granted to keep his compensation in line with
other named executive officers despite the fact that he was not affected by the elimination of the
perquisites described above. Certain of our other executives also received nominal increases in
recognition of their professional growth and accomplishments and additional responsibilities
assumed by them.
Annual Incentives.
Incentive Opportunity. In March 2010, the Committee adopted the particular corporate and personal
objectives and target award levels for 2010 under Safeguards Management Incentive Plan (the MIP)
to provide a variable incentive to each of our executives and other employees based on 2010
performance. The 2010 MIP program, which, consistent with our approach to annual incentives,
generally, emphasized teamwork among members of management to achieve key business objectives under
our 2010 strategic plan, was based on the following mix of corporate and individual objectives for
all of our executives:
|
|
80% on the achievement of corporate objectives; and |
|
|
20% on the achievement of individual objectives. |
27
Our remaining employees also participated in our 2010 MIP, with professional staff incentives being
based on the same mix of corporate and individual objectives as our executives and administrative
employee incentives being based 50% on corporate objectives and 50% on individual objectives.
We believe that short-term compensation (such as base salary and annual incentive awards) should
not be based on the short-term performance of our stock, whether favorable or unfavorable, but
rather on our executives management of Safeguard towards achieving our annual goals that we
believe will contribute to long-term growth in shareholder value. It has been our practice through
2010, that under our MIP, all of our executives earn their incentive payments based on the same
relative weighting of corporate and individual objectives. The Committee may undertake to adjust
such relative weightings as it continues to gain experience with the annual application of
Safeguards MIP in light of Safeguards overall compensation goals. The price of our stock should,
in the long term, reflect our performance, and the performance of our stock will directly affect
the value of stock options and other equity incentive awards provided to our executives as part of
our compensation program.
Performance Measures. To align the 2010 MIP with our 2010 business strategy, the Committee
established the following corporate objectives and weightings (representing 80% of the total 2010
MIP target award):
|
|
|
Weighting |
|
Corporate Objectives |
50% Partner
Company Performance
|
|
Achievement of explicit milestones or objectives (by Safeguard management and/or the
partner company itself) or specified levels of revenues or profitability for the 16
non-legacy partner companies to which the current management team had deployed capital and
in which we held an active interest as of the adoption of the 2010 MIP (see table of
specific objectives below). The Committee retained the discretion to place greater or
lesser emphasis on a particular partner company (or a particular objective) based on those
companies in which we exercise a greater or lesser level of influence and control based on
our ownership interest, board representation, etc. |
|
|
|
|
|
Partner Company |
|
Objectives / Targets (including, but not limited to) |
Advanced BioHealing
|
|
-
|
|
Sales in excess of $110 M |
|
|
-
|
|
Operating profit of at least $25 M |
|
|
-
|
|
Complete Phase I VLU clinical trials |
|
|
|
|
|
Advantedge Healthcare Solutions
|
|
-
|
|
Continued sourcing and completion of acquisitions |
|
|
-
|
|
Achieve EBITDA run rate target |
|
|
-
|
|
Augment management team |
|
|
-
|
|
Leverage Safeguard personnel for due diligence and integration support |
|
|
-
|
|
Make Safeguard bridge debt available to fund acquisitions |
|
|
|
|
|
Alverix
|
|
-
|
|
Launch commercial product |
|
|
-
|
|
Hire new CEO |
|
|
-
|
|
Complete a Series B financing |
|
|
-
|
|
Safeguard to provide interim executives, as needed |
|
|
|
|
|
Safe Central (formerly Authentium)
|
|
-
|
|
Increase revenue |
|
|
-
|
|
Establish new channel partnerships |
|
|
-
|
|
Refine market strategy |
|
|
-
|
|
Explore divestiture of certain assets |
|
|
|
|
|
Avid Radiopharmaceuticals
|
|
-
|
|
Complete AV-45 phase II and submit NDA |
|
|
-
|
|
Execute distribution relationship |
|
|
-
|
|
Select bankers for potential sale or financing |
|
|
-
|
|
Active Safeguard board and committee roles |
28
|
|
|
|
|
Partner Company |
|
Objectives / Targets (including, but not limited to) |
Beyond.com
|
|
-
|
|
Expand product offering and revenue opportunities |
|
|
-
-
|
|
Evolve technology and support structure
Consider opportunistic acquisition opportunities |
|
|
|
|
|
Bridgevine
|
|
-
|
|
Evolve management organization |
|
|
-
|
|
Develop new channel partners |
|
|
-
|
|
Define and execute in adjacent markets |
|
|
-
|
|
Refine long-term strategy |
|
|
|
|
|
Cellumen
|
|
-
|
|
Expand customer/base |
|
|
-
|
|
Manage burn rate to extend runway |
|
|
-
|
|
Pursue sale opportunities |
|
|
|
|
|
Garnet BioTherapeutics
|
|
-
|
|
Complete Phase II enrollment |
|
|
-
|
|
Hire CEO |
|
|
-
|
|
Complete Series B financing |
|
|
|
|
|
MediaMath
|
|
-
|
|
Release TerminalOne v2 |
|
|
-
|
|
Augment management team |
|
|
-
|
|
Position the company as enterprise-class DSP |
|
|
|
|
|
Molecular Biometrics
|
|
-
|
|
Achieve $7 M in revenue |
|
|
-
|
|
Complete D3 algorithm for commercial use |
|
|
-
|
|
Continue FDA trial and 501(k) submission |
|
|
|
|
|
Nupathe
|
|
-
|
|
Submit NDA |
|
|
-
|
|
Establish commercial infrastructure |
|
|
-
|
|
Execute financing |
|
|
|
|
|
Portico Systems
|
|
-
|
|
Expand PNO market leadership |
|
|
-
|
|
Augment product suit |
|
|
-
|
|
Improve service margins |
|
|
|
|
|
Quinnova Pharmaceuticals
|
|
-
|
|
Achieve $13 M in revenue |
|
|
-
|
|
Advance product pipeline |
|
|
-
|
|
Complete multiple BD relationships |
|
|
|
|
|
Swaptree
|
|
-
|
|
Grow registered user base |
|
|
-
|
|
Evaluate and implement revenue generating opportunities |
|
|
-
|
|
Establish traffic and revenue BD relationships |
|
|
|
|
|
Tengion
|
|
-
|
|
Initiate Phase I clinical trial |
|
|
-
|
|
Complete NeoKidney large animal study |
|
|
-
|
|
Complete financing |
|
|
|
50% Overall
Corporate
Performance
|
|
Overall corporate performance of Safeguard, based on the Committees subjective evaluation.
The Committee specifically listed the following illustrative examples of the types of
things they would consider in their final determination: execution of overall business
strategy (including achievement of capital return where possible without forcing premature
exits; deployment of new capital into growth and select early-stage partner companies; and
the pacing of capital deployment relative to cash availability and market conditions);
exploration of alternate sources of capital; opportunistic repurchase or refinance of
long-term debt; continued development of robust deal pipelines; continued improvement of
transparency to shareholders; continue to foster partner company referenceability;
maintenance of appropriate risk identification and mitigation strategies; management and
alignment of corporate budget with business strategy and capital availability; consistent
optimization of organization staffing and development; maintenance of appropriate levels of
liquidity; and enhancement of our market capitalization. |
29
The Committee established the specific objectives by taking into consideration the stage of
development of each of our partner companies; the anticipated relative levels of focus to be
applied by management against the various aspects of our business model during the 2010 fiscal
year; and the anticipated level of difficulty in achieving our 2010 business plan. By way of
process, the Committee, consistent with recent historical practice, directed management in late
2009 to propose a set of partner company performance objectives and overall corporate performance
objectives. The Committee and management then engaged in a back and forth dialogue regarding
several variations of the original proposal before the Committee finally adopted the final
objectives to be utilized. Within the specific parameters of the 2010 MIP, the Committee reserved
for itself a significant level of discretion in reaching final determinations of achievement levels
reached. The determination to reserve such discretion and flexibility arose from the Committees
realization, based on prior years experiences that, given the Companys business activities, as
circumstances change throughout a given fiscal year, on a macro and/or a micro level,
specific/rigid formulas or guidelines for measuring achievement set in the beginning of a year, if
strictly applied, may well incent activity that does not result in, or compensation grants that do
not match, actual shareholder value creation. The award criteria finally adopted were designed to
provide management with a meaningful guideline for meeting the Committees criteria for a target
award but not guarantee achievement or make achievement somewhat inevitable or impossible. This
approach is also intended to provide the possibility of exceeding target awards and some economic
recognition, albeit reduced, for near achievement of the target.
In connection with the finalization of the 2010 MIP corporate objectives, each executive also
prepared written individual objectives. Our Chief Executive Officers individual objectives were
reviewed and approved by the Committee. Each other named executive officers individual objectives
were reviewed and approved by our Chief Executive Officer, and each other executives individual
objectives were reviewed and approved by one of our named executive officers. The individual
objectives varied depending upon each participants roles and responsibilities.
The following table describes the individual objectives established for each of our named executive
officers.
|
|
|
|
|
Named Executive Officer |
|
Personal Objectives (including, but not limited to) |
Peter Boni |
|
(objectives tracked Safeguards overall business strategy as approved by the Board of Directors) |
|
|
-
|
|
Continued support for, and increase in the value of, our partner company holdings; |
|
|
-
|
|
The realization of some valuable exits from our partner company holdings; |
|
|
-
|
|
The replenishment of our partner company holdings with new, promising partner companies; |
|
|
-
|
|
The retirement/repurchase or restructuring of our long-term debt; |
|
|
-
|
|
Seeking alternative sources of capital; and |
|
|
-
|
|
Preparation of Safeguard for strategic growth. |
|
|
|
|
|
James Datin |
|
(objectives consistent with position as the head of our Life Sciences deal team) |
|
|
-
|
|
Supporting the achievement of the growth and milestone targets of our life sciences partner companies; |
|
|
-
|
|
Execute at least two new partner company transactions, consistent with Investment Company Act requirements; |
|
|
-
|
|
Continue building alliances with world class syndication partners; |
|
|
-
|
|
Accomplish at least one life sciences partner company exit and position additional partner companies for profitable exits in following year(s); |
|
|
-
|
|
Augment life sciences deal team in a cost effective manner; |
|
|
-
|
|
Support all efforts to seek alternative sources of capital; |
|
|
-
|
|
Support IR initiatives; and |
|
|
-
|
|
Continue to improve and upgrade Advisory Board. |
30
|
|
|
|
|
Named Executive Officer |
|
Personal Objectives (including, but not limited to) |
Kevin Kemmerer |
|
(objectives consistent with position as the head of our Technology deal team) |
|
|
-
|
|
Supporting the achievement of the growth and milestone targets of our technology partner companies; |
|
|
-
|
|
Position at least one technology partner company for exit in 2011; |
|
|
-
|
|
Complete one to two new partner company transactions in proactive areas of focus; |
|
|
-
|
|
Refine deal criteria and go-to-market strategy; |
|
|
-
|
|
Consider deal team augment; |
|
|
-
|
|
Support all efforts to seek alternative sources of capital; |
|
|
-
|
|
Continue to improve and upgrade Advisory Board; |
|
|
-
|
|
Support IR initiatives; and |
|
|
-
|
|
Facilitate transparency of partner companies. |
|
|
|
|
|
Brian Sisko |
|
(objectives consistent with role of General Counsel and member of executive senior management team) |
|
|
-
|
|
Orchestrate and execute a debt refinancing transaction regarding our outstanding debentures; |
|
|
-
|
|
Create and implement risk management assessment process; |
|
|
-
|
|
Incorporate all newly created regulatory compliance/corporate governance requirements; |
|
|
-
|
|
Successful completion of shelf registrations; |
|
|
-
|
|
Increase level of involvement with partner companies; |
|
|
-
|
|
Participate in and support all efforts regarding alternative sources of capital; |
|
|
-
|
|
Assist and support all partner company exit opportunities; and |
|
|
-
|
|
Oversee creation of active best practices program for partner companies. |
|
|
|
|
|
Stephen Zarrilli |
|
(objectives consistent with role of Chief Financial Officer and member of executive senior management team) |
|
|
-
|
|
Orchestrate and execute a debt refinancing transaction regarding our outstanding debentures; |
|
|
-
|
|
Support completion of shelf registration process; |
|
|
-
|
|
Develop initial co-participation initiatives; |
|
|
-
|
|
Pursue development of mezzanine debt fund; |
|
|
-
|
|
Increase level of involvement with partner companies; and |
|
|
-
|
|
Participate in and support all efforts regarding alternative sources of capital. |
Consistent with their respective employment agreements and Safeguards overall compensation
philosophy, the Committee set the following target awards for 2010 for our named executive
officers:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2009 MIP Target |
|
|
2010 MIP Target |
|
|
2011 MIP Target |
|
|
|
Variable |
|
|
Variable |
|
|
Variable |
|
Name |
|
Incentive* |
|
|
Incentive |
|
|
Incentive* |
|
Peter J. Boni |
|
$ |
650,000 |
|
|
$ |
661,500 |
|
|
$ |
700,000 |
|
James A. Datin |
|
$ |
390,000 |
|
|
$ |
401,500 |
|
|
$ |
425,000 |
|
Kevin L. Kemmerer |
|
$ |
357,500 |
|
|
$ |
387,500 |
|
|
$ |
410,000 |
|
Brian J. Sisko |
|
$ |
250,000 |
|
|
$ |
261,500 |
|
|
$ |
281,000 |
|
Stephen T. Zarrilli |
|
$ |
250,000 |
|
|
$ |
261,500 |
|
|
$ |
400,000 |
|
|
|
|
* |
|
2009 and 2011 MIP target variable incentive amounts have been included for comparison purposes. |
The Committee notes that it has been the Committees recent practice to maintain the ratio between
the annual base salary and the annual MIP target variable incentive amount that was first
established for a particular executive upon hire (or later renegotiation of terms of employment).
This approach is not a formal policy nor is it a contractual requirement. In connection with the
elimination of perquisites as otherwise described in this analysis, beginning in 2010, the
Committee varied from the practice in that target variable incentive levels for 2010 were increased
for the
named executive officers by a fixed amount of $11,500 per named executive officer affected by the
elimination of the perquisites and the increase in base salary. Even though Mr. Zarrilli was not
affected by the perquisite elimination, his base salary and target variable incentive amount were
increased to keep his compensation in line with the other named executive officers.
31
Payouts. There were no mandatory minimum awards payable under the 2010 MIP. The actual incentive
awards paid to participants were determined based upon the level of achievement of the quantitative
and qualitative corporate and individual performance objectives and were measured in the aggregate
on a sliding scale basis (e.g., for executives and professional staff, achievement of objectives
totaling 50 percent would result in payment of 50% of the target award, achievement of objectives
totaling 100 percent would result in payment of 100% of the target award and achievement of
objectives totaling 150 percent would result in payment of 150% of the target award). Payments
under the 2010 MIP were limited to 150% of each individuals target award.
Under the terms of our 2010 MIP, the Committee had the ability to make payments to participants in
cash and/or equity. There was no requirement that any particular portion of any payments may be
made in any particular form. In late 2010 and early 2011, the Committee reviewed our performance
against the quantitative and qualitative corporate objectives set forth above and preliminarily
determined the following payout levels. The finalization of the payouts was conditioned upon the
completion of the audit of our 2010 financial statements and internal controls over financial
reporting without any unexpected material adjustments. Such completion occurred on March 4, 2011,
when our Annual Report on Form 10-K for the 2010 fiscal year was filed.
|
|
|
|
|
|
|
|
|
Payout |
|
|
|
|
|
Level |
|
|
|
|
|
(as a |
|
|
|
|
|
percentage |
|
|
|
Corporate Objectives |
|
of target) |
|
|
Factors Affecting Determination |
Partner Company Performance
|
|
|
103 |
% |
|
In approving a payout of 103% of the
target award total in this category, the
Committee noted the following
accomplishments against the applicable
objectives: |
|
|
|
|
|
|
|
|
|
|
|
|
|
- Substantial increase in value
accomplished in some of Safeguards
largest partner companies; |
|
|
|
|
|
|
- Management enhancements accomplished at
seven partner companies; |
|
|
|
|
|
|
- Accretive acquisition transactions
accomplished by four partner companies; and |
|
|
|
|
|
|
- Divestiture of non-core business line by
one partner company. |
|
|
|
|
|
|
|
|
|
|
|
|
|
In the aggregate, the Committee concluded
that 11 out of the 16 partner companies
included in the MIP for 2010 finished the
year on or ahead of the milestones
established at the outset of the year.
They also concluded that of such 11
companies, five finished the year
significantly ahead of plan. |
32
|
|
|
|
|
|
|
|
|
Payout |
|
|
|
|
|
Level |
|
|
|
|
|
(as a |
|
|
|
|
|
percentage |
|
|
|
Corporate Objectives |
|
of target) |
|
|
Factors Affecting Determination |
Overall Corporate Performance
|
|
|
130 |
% |
|
In awarding a 130% payout in this
category, the Committee noted the
following accomplishments against the
applicable objectives: |
|
|
|
|
|
|
|
|
|
|
|
|
|
- Two exit transactions accomplished
producing aggregate net initial proceeds
to Safeguard of $178 million (with high
likelihood of additional proceeds from the
Avid exit within one year based on
achievement of milestones; and potential
for substantial additional proceeds based
on difficult, but achievable, milestones).
Initial net proceeds reflect minimum 3x
cash-on-cash return; |
|
|
|
|
|
|
- $47 million debt exchange transaction
initiated, negotiated and accomplished in
Spring 2010. |
|
|
|
|
|
|
- Share price increase of over 70% from
1/1/2010 to 12/31/2010; |
|
|
|
|
|
|
- Addition of three new covering analysts; |
|
|
|
|
|
|
- Maintenance of operating expense levels
consistent with budget; and |
|
|
|
|
|
|
- Cash, cash equivalents and marketable
securities of approximately $126 million
(excluding escrowed amounts and restricted
cash) on hand at year end. |
|
|
|
|
|
|
|
|
|
|
|
|
|
In the aggregate, the Committee concluded
that Safeguard had far exceeded
expectations regarding: i) the
accomplishment of significant exit
transactions during the year; ii) the
year-over-year increase in the value of
its partner companies (despite the
write-off of two of Safeguards partner
companies); and Safeguards initiatives to
increase its liquidity position and market
capitalization. The Committee further
concluded that Safeguard had met its plans
regarding exploration of relationships and
initiatives that could lead to the
development of alternate sources of
capital for Safeguard and to further
strategic growth. The Committee lastly
concluded that Safeguard had not met
expectations relating to the deployment of
capital into new partner companies.* |
Total Percentage
|
|
|
117 |
% |
|
|
|
|
|
* |
|
It should be noted that accomplishments directly related to our holdings in Clarient were not
weighted in connection with the determination of 2010 MIP awards. |
33
Following the end of the 2010 calendar year, each executive completed a self-assessment of his
achievement of individual objectives (representing 20% of the total 2010 MIP target award). The
Chief Executive Officers self-assessment was a component of the annual CEO performance review
conducted by the Nominating & Corporate Governance Committee. The Committee reviewed with the
Nominating & Corporate Governance Committee its assessment of the performance of the Chief
Executive Officer, including his achievement of individual objectives. Regarding the performance of
each of the other named executive officers, the Committee based its assessment of their
achievements of individual objectives principally on the recommendation made by our Chief Executive
Officer. The Committees determinations regarding the individual achievement levels of each of the
named executive officers
were as follows: Mr. Bonis individual performance component was determined to be 110%, based
principally upon the same accomplishments that the Committee noted regarding overall corporate
performance, as described above, since Mr. Bonis personal objectives mirrored the overall
corporate objectives which had been established. Mr. Datins individual performance was determined
to be 110% based upon: i) the fact that the majority of the Life Sciences partner companies
exceeded their performance plans; ii) the extraordinary value realization related to Clarient and
Avid; and iii) the augmentation of the Life Sciences deal team capabilities and capacity through
the use of EIRs and active advisory board members. Mr. Kemmerers individual performance component
was determined to be 90%, based upon: i) advances made in the performance, talent base and value of
the technology partner companies as a whole; ii) the positioning of several of the technology
partner companies for future exit; and iii) the establishment of a FinTech initiative and the use
of an EIR in connection with such initiative. Mr. Siskos individual performance was determined to
be 110% based upon i) the timely and efficient execution of Safeguards shelf registrations in
coordination with other Company activities; ii) Board level activity within Safeguards partner
companies; iii) creativity in contributing to achievement of Safeguards game plan; iv) flexibility
in approach to achieving core objectives of Safeguard; v) the hiring and training of a new attorney
to support deal team activity; and vi) demonstrated initiative in pursuing professional
development. Mr. Zarrillis individual performance was determined to be 110% based upon; i) the
timely and well-executed completion of Safeguards shelf registrations; ii) creative approach to
pursuit of alternative sources of capital for Safeguard; iii) the pursuit of debt capital
deployment opportunities; and iv) participation in advising and building value in our partner
companies.
Based on its review of the achievement of both quantitative and qualitative 2010 MIP objectives,
the Committee authorized the following individual awards to Safeguards named executive officers.
The Committee determined, based on consultations with the Committees independent consultant and
analysis of data related to incentive payment practices being followed within Safeguards peer
group and throughout the United States financial services industry, as a whole, to pay 100% of 2010
MIP payments to our executives in cash. The Committees decision to pay all 2010 MIP awards in
cash was based upon two principal company-specific factors: first and foremost was Safeguards
cash position; and second was the relatively low level of equity available for grant in Safeguards
long-term incentive plans. The Committee recognizes that these MIP awards are part of the annual
incentive component of our compensation policies and not part of long-term incentive compensation
and, so long as Safeguards liquidity position is strong, the Committee will tend towards paying
annual incentive amounts in cash rather than equity. The utilization of equity as part of the MIP
award process will be considered on a year-by-year basis and will not be driven by any rigid
guideline.
The cash amounts paid to our named executive officers also are presented in the Summary
Compensation Table under Non-Equity Incentive Plan Compensation. The cash payments were made to
each executive, following completion of the audit of our financial statements on March 4, 2011.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Variable |
|
Name |
|
Payout Level (1) |
|
|
Incentive Payment |
|
Peter J. Boni |
|
|
115.6 |
|
|
$ |
764,694 |
|
James A. Datin |
|
|
115.6 |
|
|
$ |
464,134 |
|
Kevin L. Kemmerer |
|
|
111.6 |
|
|
$ |
432,450 |
|
Brian J. Sisko |
|
|
115.6 |
|
|
$ |
302,294 |
|
Stephen T. Zarrilli |
|
|
115.6 |
|
|
$ |
302,294 |
|
|
|
|
|
|
|
|
|
Named Executive Officers, as a group (5 persons) |
|
|
|
|
|
$ |
2,265,866 |
|
|
|
|
(1) |
|
In percentage terms versus targeted incentive amount. |
It should be noted that the Committee is in the process of instituting a clawback policy that will
formally give Safeguard the ability to recover portions of the compensation paid, including
incentive compensation, to our named executive officers and others under certain circumstances
involving financial results restatements and ethical misconduct. The Committee is undertaking this
initiative, not in response to any particular situation or circumstance, but as a natural extension
of the Committees commitment to sound executive compensation practices and effective corporate
governance. All grants made in 2010 will be subject to such clawback policy.
34
Long-Term Incentives. The principal approach utilized by the Committee to meet the need for a
long-term incentive component to Safeguards executive compensation program has been the granting
of significant amounts of equity to our named executive officers. Historically, this was
accomplished almost exclusively in the form of stock options. More recently, the Committee has
also issued equity in the form of restricted stock and performance stock units. Our equity
compensation plans allow for the grant of options, restricted stock awards and such other
equity-based awards as the Committee may determine to be appropriate from time to time. It should
be noted that, as described above under 2010 Compensation Program Payouts, the Committee chose
to pay all of the 2010 MIP awards in cash, whereas a portion of the 2009 MIP awards were paid in
the form of stock grants, and a portion of the 2008 MIP awards were paid in the form of restricted
stock.
As noted above, we compete for executive talent with venture capital and private equity firms, and
we review comparative information regarding venture capital and private equity industry
compensation practices as part of our overall analysis. In such industries, executives (referred
to as managing partners) typically have compensation programs heavily weighted towards long-term
incentive, structured as a share of the funds profits, payable in cash (referred to as carry).
We currently do not provide our executives with a cash compensation program tied directly to gains
from our sales of our partner company holdings. Instead, as part of our overall process of
composing a complete approach to executive compensation, we review our equity compensation plans in
light of the type of economic benefit and performance metrics that would be included in a carry
approach to compensation. We compare the initial equity awards made to our named executive
officers against our assessment of the carry which would typically be provided to executives in
positions of comparable responsibility at private equity and/or venture capital firms at that time.
Based upon information available to the Committee through its consultant, we continually reassess
the competitiveness of our executives long-term compensation opportunity against a carry
methodology as well as other relevant metrics from other types of businesses within our peer group.
The ultimate potential value of the equity grants is intended to be competitive with those held by
comparable executives in the comparison data reviewed by the Committee (as adjusted for the senior
executives experience).
In order to undertake a discussion of the Committees work regarding long-term incentives during
2010, it is relevant to revisit issues related to long-term incentives confronted in 2008 and 2009.
The Committees deliberations with regard to long-term incentives during 2008 were made
increasingly challenging by a variety of factors the economic environment impacted the
opportunity to realize the value of long-term incentives, and the retentive value of long-term
incentive grants made to the named executives upon hire declined precipitously through the course
of 2008. In an effort to better approximate a carry approach, the Committee considered a variety
of alternatives for long-term incentives, including cash, restricted stock, and stock options, with
all of these approaches tied to gains derived by Safeguard from sales of our partner company
interests. The Committee decided to continue the use of options as the principal component of its
long-term incentive program, but changed the performance criteria for new grants from the
market-based approach (described below) which had been utilized since 2005, to the
capital-return approach (described below). The Committee made this change in the belief that this
vehicle best ties the reward to the factors critical to the creation of shareholder value.
All of our stock options are granted with an exercise price equal to the average of the high and
low trading prices of our common stock on the date of grant. Therefore, the options will have
value only if the market price increases after that date and, in the case of options that vest upon
achievement of specified performance milestones, only if the specified performance milestones are
achieved.
We refer to options, restricted stock and performance stock units that vest upon achievement of
specified performance milestones as performance-based. At present, we have issued and
outstanding two types of performance-based equity: market-based vesting and capital-return based
vesting (initiated in 2008). Both of these types of performance-based equity are described in
detail below.
35
In general, for executive personnel, the Committee has established the following model for
allocating equity grants (both initial and any annual grants) between equity grants which are
subject to simple time-based vesting and performance-based equity:
|
|
25% of the total underlying shares are subject to time-based vesting; of such amount, 25%
vests on the first anniversary date of the grant date and the remaining 75% vests in 36 equal
monthly installments on the same date of each month thereafter; and |
|
|
|
75% of the total underlying shares are subject to performance-based vesting. |
The Committee believes that allocating equity grants in such a fashion aligns the long-term
interests of Safeguard management and our shareholders. The Committee may infrequently grant
equity allocated in a different manner, in special circumstances. All equity grants to our named
executive officers in 2010 were allocated, between time-based vesting and performance-based
vesting, in the above manner.
Market-based Options. Our market-based vesting options vest as Safeguards per share price on the
NYSE achieves certain specified levels. The Committee began utilizing these market-based vesting
options during 2005 and continued to utilize them through the second quarter of 2008. Our
executives will not benefit from such option grants unless our stock price achieves and sustains a
targeted stock price (based on the average closing price of a share of our common stock as reported
on the NYSE composite tape for 20 consecutive trading days).
The following table shows the per share stock price levels at which portions of the shares
underlying the market-based vesting options granted in 2005 and 2006 to Messrs. Boni, Datin and
Kemmerer will vest:
|
|
|
|
|
|
|
Per Share Stock Price |
|
Percentage of Shares Underlying Options That Vest |
|
(as adjusted to reflect 8/2009 reverse stock split) |
|
First 10% |
|
$ |
12.2154 |
|
Next 20% |
|
$ |
18.9288 |
|
Next 30% |
|
$ |
27.8796 |
|
Final 40% |
|
$ |
39.0684 |
|
The market-based options issued to Mr. Sisko in 2007 and to Messrs. Kemmerer and Zarrilli during
2008 will vest as follows:
|
|
|
|
|
|
|
Per Share Stock Price |
|
Percentage of Shares Underlying Options That Vest |
|
(as adjusted to reflect 8/2009 reverse stock split) |
|
First 20% |
|
$ |
18.9288 |
|
Next 30% |
|
$ |
27.8796 |
|
Next 40% |
|
$ |
39.0684 |
|
Final 10% |
|
$ |
43.3476 |
|
Market-based options also may vest on a pro rata basis if the per share stock price is between the
designated stock price levels set forth in the above tables for 20 consecutive trading days. We
measure for these pro rata vestings every six months. For example, based on the stock price levels
in the first table above, if the first 30% of the options had already vested and within the next
six-month window, the highest average closing price of a share of our common stock as reported on
the NYSE composite tape over 20 consecutive trading days equaled $23.4042, an additional 15% of the
shares underlying the options would vest.
We do not have any other forms of market-based equity grants besides our market-based options.
Capital-Return Model. During the third quarter of 2008, based upon discussions with the Committees
consultant and in an attempt to 1) formally incorporate the annual granting of equity as part of
the annual total compensation package; 2) better approximate the carry concept described above;
and 3) better link compensation to two principal elements of Safeguards business plan for
producing enhanced shareholder value, increasing the value of our partner company interests and
consummating exit transactions to realize such value, the Committee formulated the following
capital-return model. The principle behind the capital-return model is to vest the underlying
equity as partner company exit transactions produce aggregate cash returns to Safeguard in excess
of certain predetermined levels. In order to create a starting point for the use of this vesting
approach, the Committee formed a group consisting of all of Safeguards partner companies existing
as of September 30, 2008, other than Clarient (the Initial Group) and tied the vesting to
predetermined levels of net cash proceeds returned to Safeguard based on exit transactions
involving the Initial Group. The model calls for vesting to be calculated annually on September 30
of
each calendar year. Vesting will only begin to occur after a hurdle amount of proceeds are produced
(an amount equal to 100% of aggregate cash deployed in the Initial Group, plus an amount
approximating Safeguards annual cost of overhead). All instruments will become vested upon
achievement of a predetermined target amount of proceeds (an amount equal to three times aggregate
cash deployed in the Initial Group). After the hurdle amount is reached, the instruments will vest
on a linear basis relative to additional proceeds produced beyond the hurdle amount until such time
as 100% are vested when the target amount of proceeds is reached. Adjustments to the hurdle amount
and the target amount will be made if and when Safeguard deploys additional capital into any of the
Initial Group.
36
The Committee determined that the instruments issued in 2008 would all be options. None of such
Initial Group capital-return options have vested as of the date hereof. It was contemplated that,
on an annual basis going forward, on or about the anniversary date of the formation of the Initial
Group, the Committee would create an additional grouping of partner companies defined as companies
into which Safeguard first deployed capital during the preceding 12 months. The vesting of any
stock option or other equity issuances to be made at that time (or within the next 12 months) in
the normal course of the Committees management of executive compensation equity matters would be
tied to net proceeds produced from exit transactions involving such group of partner companies.
Consistent with such expectations, in Fall 2009, the Committee issued additional capital-return
options as well as performance stock units (which also vest based on the capital-return model)
pegged to a group of partner companies first funded by Safeguard in the prior 12 months. During
the Fall of 2010, as the Committee took under consideration additional equity grants consistent
with this capital-return model, the Committee made a determination to expand the group of partner
companies used for measurement purposes to include partner companies into which Safeguard first
deployed capital in the last 24 months. This was done because of the small number of partners
companies which were first funded in the prior 12 months. The Committee felt it inappropriate to
link the vesting of the relevant equity grants to such a small pool of partner companies. This
practice, as it may be revised to accommodate specific circumstances, is expected to continue
annually. The Fall 2010 grants were split evenly, on a value basis, between options and restricted
equity vehicles.
For the Fall 2009 and Fall 2010 grants, the hurdle amounts (the point at which vesting begins to
occur) equal 100% of capital deployed into the relevant group of partner companies, plus an amount
based on Safeguards annual cost of overhead. For such grants, the target amounts (the point at
which all instruments become vested) equal three times capital deployed in the relevant group of
partner companies.
The Committee annually reviews the equity awards held by our executives and other employees and
also may consider awards periodically during a year in an effort to retain and motivate employees
and to ensure continuing alignment of executive and shareholder interests. Information regarding
the equity grants made to our named executive officers during 2010 can be found below under
Executive Compensation Grants of Plan-Based Awards 2010.
Subject to availability under our shareholder approved equity compensation plans, we expect to
continue to use stock options and other equity awards as part of our executive compensation
program, including performance-based options.
Stock Option/Equity Granting Process. The Committee is responsible for equity grants under our
equity compensation plans. The Committee approves and grants all equity awards to our executives,
employees and advisory board members, with the exception of those grants for which the Committee
has delegated authority to the Chief Executive Officer which are described below. Equity grants to
directors are generally approved by the Board; however, in those cases where the Board has approved
the size and form of recurring annual service grants, the Committee may authorize grants without
further Board approval.
Grants may be made at regularly scheduled meetings or at special meetings convened to approve
compensation arrangements for newly hired executive officers or for executive officers who have
been promoted or are otherwise subject to changes in responsibilities. During 2007, the Committee
determined that, as a matter of best practice, recurring grants to directors would be made on or
about the date of Safeguards annual meeting of shareholders. During 2008, the Committee further
determined that it would also begin utilizing the end of Safeguards fiscal third quarter each year
as an acceptable and administratively convenient time to make annual determinations regarding
executive equity compensation matters. It is presently contemplated that, at that time in each
calendar year going forward, and in connection with the process described above regarding
Safeguards capital-return model, the Committee may issue additional options (or other forms of
incentive equity) to some or all of Safeguards executives. This annual process was established in
2008 in recognition of the fact that the core of Safeguards senior management team was established
beginning in 2005 and that, based on the term of Safeguards option grants, it would be appropriate
to begin an annual option review and potential programmatic supplemental grant designed to deliver
an annual long-term incentive value relative to each executives roles and responsibilities. The
Committee believes that granting equity on an annual basis will 1) provide greater alignment
between the performance achieved and the value realized; 2) reinforce equity value as an important
component of each executives annual total compensation; and 3) recognize each executives ongoing
role in achieving results rather than the point in time that he joined Safeguard.
37
The Committee has delegated to our Chief Executive Officer the authority to make equity grants
between regularly scheduled Committee meetings (primarily to new hires and new advisory board
members), provided that the aggregate number of shares granted may not exceed 50,000 shares, the
maximum number of shares allocated to any one employee may not exceed 20,000 shares and the
aggregate number of shares allocated to any one advisory board member may not exceed 1,000 shares.
A report is made to the Committee at each of its regularly scheduled meetings regarding any grants
that our Chief Executive Officer has approved since the date of the last report, following which
the aggregate number of shares available is reset to 50,000 shares. The Chief Executive Officer is
not authorized to make equity grants to executives or directors without prior Committee approval of
the specific grant contemplated.
It recently has become our practice to make all employee grants of options, subject to limited
exceptions for new hires, on fixed quarterly grant dates. Grants to newly retained consultants or
advisors may be made on fixed quarterly grant dates, or the later of the date the award is approved
or the date of commencement of services. The exercise price for all stock options granted under
our equity compensation plans is the average of the high and low trading prices of our common stock
as reported on the NYSE composite tape on the date of grant, which we believe reflects a commonly
utilized practice.
Nonqualified Deferred Compensation. Our executives may defer compensation under our qualified
401(k) plan (subject to the limits imposed by the Internal Revenue Code) but generally, due to the
structure of our 401(k) plan, the most highly compensated of our executives (including our named
executive officers) were not eligible to receive matching company contributions under that plan for
calendar years through 2008. In lieu of such a matching 401(k) contribution, such executives were
eligible to participate in our nonqualified deferred compensation plan, which is an unfunded plan
that did not allow participants to elect to defer compensation but did allow participants to obtain
credits, in the form of Safeguard contributions allocated to accounts for the benefit of
participants. We offered this nonqualified deferred compensation plan to those executives excluded
from matching contributions in light of their ineligibility to obtain a Company matching
contribution under our qualified 401(k) plan. During 2008, the Committee approved a change to our
401(k) plan which allowed matching contributions for all of our employees for calendar years
beginning with 2009. Therefore, no further contributions are expected to be made under our
nonqualified deferred compensation plan for calendar years beyond 2008. Amounts accrued for prior
periods will remain credited, and earnings on those prior amounts will continue to be credited, to
prior participants in accordance with the terms of the plan. Additional information regarding
participation in this plan by named executive officers can be found below under Executive
CompensationNonqualified Deferred Compensation 2010.
Perquisites (fringe benefits). Previously, certain of our executives were contractually entitled
to a few benefits that were not otherwise available to our employees generally. Such additional
benefits were eliminated effective January 1, 2010. We do not provide a defined benefit pension
arrangement, post-retirement health coverage or similar benefits for any of our executives. During
2010, we provided universal life insurance coverage ranging from $750,000 to $1,000,000 to each of
our named executive officers.
In connection with the Committees deliberations regarding 2010 Base Salary amounts for our named
executive officers, it was determined that car allowances, non-accountable expense allowances and
Executive Medical perquisites would be eliminated effective January 1, 2010. As described above,
the Committee did adjust base salaries of the affected named executive officers in connection with
the elimination of such perquisites.
38
Severance and
Change-in-Control Arrangements
Each of our named
executive officers has an agreement with Safeguard which provides certain
benefits in the event of termination of his employment by Safeguard without
cause or by the
officer for good reason (as defined in the agreements).
Upon the
occurrence of a termination event, each executive will be entitled to those
benefits
outlined in his agreement with us, which may include a multiple of his then
current base salary,
payment of his pro rata bonus for the year of termination or a multiple of the
greater of his
target bonus for the year of termination or the average of his actual bonuses
for up to the last
three years, accelerated vesting of equity awards and extension of the
post-termination exercise
period within which some or all of the equity awards held by the executive may
be exercised,
coverage under our medical, health and life insurance plans for a designated
period of time, and
outplacement services or office space. See Potential Payments upon
Termination or Change in
Control elsewhere herein for a summary of the specific benefits that
each executive will receive
upon the occurrence of a termination event.
Unlike
single trigger change-in-control arrangements that pay out
immediately upon a change in
control, most of the benefits to which our named executive officers are
entitled under their
agreements in the event of a change in control require a
double trigger, namely a change in
control coupled with a loss of employment or a substantial change in job
duties. We believe a
double trigger provides retention incentives as well as continuity
of management in the event of
an actual or threatened change in control. However, we note that the
acceleration of the vesting
of the stock options that have been granted to Mr. Boni require only a
single trigger to be
effective that is, only a change in control. This arrangement was
specifically negotiated by
Mr. Boni as a condition to his agreement to join Safeguard. Since equity
represents a significant
portion of Mr. Bonis total compensation, we believe that this
single trigger can be an important
retention device during changein-control discussions.
Deductibility
of Executive Compensation
The Committee
considers the potential impact of Section 162(m) of the Internal Revenue Code
in
structuring executive compensation. Section 162(m) disallows a tax deduction
for any publicly held
corporation for certain executive compensation exceeding $1,000,000 per person
in any taxable year
unless it is performance based within the meaning of
Section 162(m). We believe the stock
options awarded under our equity compensation plans are in compliance with the
provisions of
Section 162(m). The portion of cash compensation paid to Mr. Boni
for 2010 in excess of $1,000,000
was not performance-based compensation within the meaning of
Section 162(m) and, therefore, was
not deductible by Safeguard. We believe that providing an appropriate level of
cash compensation
and maintaining flexibility in determining compensation may be more important
than preserving this
tax deduction. Therefore, the Committee does not currently plan to take any
action to qualify any
of our incentive compensation plans under Section 162(m).
Stock Ownership
Guidelines
Our Board
established stock ownership guidelines, effective December 31, 2005, that
are designed to
closely align the long-term interests of our named executive officers with the
long-term interests
of our shareholders. The guidelines provide that each named executive officer
should attain an
equity position in our common stock equal to two times annual base salary. The
ownership level
should be achieved (i) within five years of December 31, 2005 for
executive officers who were
employed on that date or (ii) for individuals who were not employees on
December 31, 2005, by the
end of the fifth full calendar year following the year in which the executive
officer was hired or
became an executive officer. The Nominating & Corporate Governance
Committee monitors compliance
as of the end of each calendar year. Shares counted toward these guidelines
include:
|
|
Shares beneficially owned by the executive officer; |
|
|
|
Vested shares of restricted stock; |
|
|
|
Vested deferred stock units that have been credited to the executive
officer; and |
|
|
|
Shares underlying vested, in-the-money options. |
Based on
information they have provided to us, all of our named executive officers,
including our
Chief Executive Officer, have achieved the required ownership levels.
39
Prohibition on
Speculation in Safeguard Stock
Our company policy
on securities trading by company personnel prohibits our named executive
officers, directors and other employees from engaging in activities with
regard to our stock that
can be considered as speculative, including but not limited to, short selling
(profiting if the
market price of our securities decreases); buying or selling publicly traded
options (e.g., a put
option, which is an option or right to sell stock at a specific price prior to
a specified date, or
a call option, which is an option or right to buy stock at a specific price
prior to a specified
date); and hedging or any other type of derivative arrangement that has a
similar economic effect.
Our executive officers and directors also are prohibited from pledging,
directly or indirectly, our
common stock or the stock of any of our partner companies, as collateral for
indebtedness.
COMPENSATION
COMMITTEE REPORT
We have reviewed
and discussed the foregoing Compensation Discussion and Analysis with
management.
Based on our review and discussion with management, we have recommended to the
Board of Directors
that the Compensation Discussion and Analysis be included in the
Companys Annual Report on Form
10-K for fiscal year 2010 and the Companys proxy statement for its 2011
annual meeting of
shareholders.
Members of the
Compensation Committee:
|
|
|
|
|
|
|
Julie A.
Dobson, Chairperson
|
|
Andrew E. Lietz
|
|
George D. McClelland
|
|
John J. Roberts |
40
EXECUTIVE
COMPENSATION
Summary
Compensation Table Fiscal Years Ended December 31, 2010, 2009 and
2008
The table below is
a summary of total compensation paid to or earned by our named executive
officers for the fiscal years ended December 31, 2010, 2009 and 2008.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-Equity |
|
|
Pension Value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Incentive |
|
|
and |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Plan |
|
|
Nonqualified |
|
|
All Other |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock |
|
|
Option |
|
|
Compen- |
|
|
Deferred |
|
|
Compen- |
|
|
|
|
Name and |
|
|
|
|
|
Salary |
|
|
Bonus |
|
|
Awards |
|
|
Awards |
|
|
sation |
|
|
Compensation |
|
|
sation |
|
|
Total |
|
Principal Position |
|
Year |
|
|
($) |
|
|
($)(1) |
|
|
($)(2)(3) |
|
|
($)(2)(4) |
|
|
($) |
|
|
Earnings ($) |
|
|
($)(5) |
|
|
($) |
|
Peter J.
Boni |
|
|
2010 |
|
|
|
673,000 |
|
|
|
175,000 |
|
|
|
182,354 |
|
|
|
186,107 |
|
|
|
764,694 |
|
|
|
6,802 |
|
|
|
49,617 |
|
|
|
2,037,574 |
|
President and
Chief |
|
|
2009 |
|
|
|
650,000 |
|
|
|
75,000 |
|
|
|
307,031 |
|
|
|
260,703 |
|
|
|
598,000 |
|
|
|
10,805 |
|
|
|
69,323 |
|
|
|
1,970,862 |
|
Executive
Officer |
|
|
2008 |
|
|
|
650,000 |
|
|
|
|
|
|
|
|
|
|
|
667,736 |
|
|
|
428,964 |
|
|
|
|
|
|
|
74,323 |
|
|
|
1,821,023 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
James A.
Datin |
|
|
2010 |
|
|
|
413,000 |
|
|
|
175,000 |
|
|
|
83,553 |
|
|
|
85,320 |
|
|
|
464,134 |
|
|
|
6,802 |
|
|
|
19,834 |
|
|
|
1,247,643 |
|
Executive Vice
President |
|
|
2009 |
|
|
|
390,000 |
|
|
|
75,000 |
|
|
|
143,691 |
|
|
|
122,009 |
|
|
|
378,300 |
|
|
|
10,805 |
|
|
|
41,564 |
|
|
|
1,161,369 |
|
and Managing
Director, Life Sciences |
|
|
2008 |
|
|
|
390,000 |
|
|
|
|
|
|
|
|
|
|
|
333,875 |
|
|
|
266,569 |
|
|
|
|
|
|
|
46,961 |
|
|
|
1,037,405 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Kevin L.
Kemmerer |
|
|
2010 |
|
|
|
399,000 |
|
|
|
|
|
|
|
83,553 |
|
|
|
85,320 |
|
|
|
432,450 |
|
|
|
8,954 |
|
|
|
17,309 |
|
|
|
1,026,586 |
|
Executive Vice
President |
|
|
2009 |
|
|
|
357,500 |
|
|
|
|
|
|
|
168,253 |
|
|
|
142,866 |
|
|
|
325,325 |
|
|
|
14,224 |
|
|
|
40,022 |
|
|
|
1,048,190 |
|
and Managing
Director, Technology |
|
|
2008 |
|
|
|
309,337 |
|
|
|
|
|
|
|
|
|
|
|
638,350 |
|
|
|
204,306 |
|
|
|
|
|
|
|
45,081 |
|
|
|
1,197,074 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Brian J.
Sisko |
|
|
2010 |
|
|
|
363,000 |
|
|
|
125,000 |
|
|
|
66,889 |
|
|
|
68,252 |
|
|
|
302,294 |
|
|
|
2,953 |
|
|
|
20,534 |
|
|
|
948,922 |
|
Senior Vice
President and |
|
|
2009 |
|
|
|
340,000 |
|
|
|
50,000 |
|
|
|
71,231 |
|
|
|
60,483 |
|
|
|
245,840 |
|
|
|
4,691 |
|
|
|
42,763 |
|
|
|
815,008 |
|
General
Counsel |
|
|
2008 |
|
|
|
340,000 |
|
|
|
50,000 |
|
|
|
|
|
|
|
72,292 |
|
|
|
176,771 |
|
|
|
|
|
|
|
48,109 |
|
|
|
687,172 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stephen T.
Zarrilli |
|
|
2010 |
|
|
|
363,000 |
|
|
|
125,000 |
|
|
|
66,889 |
|
|
|
68,252 |
|
|
|
302,294 |
|
|
|
|
|
|
|
21,723 |
|
|
|
947,158 |
|
Senior Vice
President and |
|
|
2009 |
|
|
|
340,000 |
|
|
|
50,000 |
|
|
|
71,231 |
|
|
|
60,483 |
|
|
|
245,840 |
|
|
|
|
|
|
|
21,681 |
|
|
|
789,235 |
|
Chief Financial
Officer |
|
|
2008 |
|
|
|
198,333 |
|
|
|
113,750 |
|
|
|
|
|
|
|
1,099,875 |
|
|
|
|
|
|
|
|
|
|
|
14,006 |
|
|
|
1,425,964 |
|
|
|
|
(1) |
|
For 2010, the amounts reported represent discretionary bonuses awarded
by the Compensation
Committee for exceptional performance which was outside of the scope of the
corporate
objectives established under our 2010 Management Incentive Plan (2010
MIP). Amounts earned
by our named executive officers under our 2010 MIP are reported under
Non-Equity Incentive
Plan Compensation. |
|
(2) |
|
Consistent with SEC rules, stock and option awards are required to be
valued using the
aggregate grant date fair value computed in accordance with stock-based
compensation
accounting rules (FASB ASC Topic 718). Even though awards may be forfeited,
the amounts
reported do not reflect this contingency. Amounts reported for these awards do
not reflect
our accounting expense for these awards during the year and may not represent
the amounts that
our named executive officers will actually realize from the awards. Whether,
and to what
extent, our named executive officers realize value will depend on (i) the
achievement of the
market-based or the performance-based vesting criteria associated with certain
stock options
and performance stock units (PSUs) awarded; (ii) our stock
price; and (iii) an individuals
continued employment for awards that are subject to time-based vesting.
Vesting of awards
held by our named executive officers may be accelerated in certain
circumstances as detailed
below under Potential Payments upon Termination or Change in
Control. |
|
(3) |
|
For 2010, the Compensation Committee awarded a combination of
time-based vesting restricted
stock and PSUs. The fair value of the restricted stock and PSUs is based on
$15.105 per
share, which was the average of the high and low trading prices of a share of
our common stock
on the grant date. The PSUs are subject to performance-based vesting and vest
based on the
aggregate cash produced as a result of exit transactions involving certain of
our partner
companies relative to the amount of cash deployed in connection with such
partner companies
over a 10-year period, as described in detail under Compensation
Discussion and Analysis
Long-Term Incentives. Each PSU entitles a named executive officer to
receive one share of
Safeguard common stock on or about the date upon which the PSU vests. Assuming
the highest
level of performance conditions will be achieved for the PSUs, the full grant
date fair value
for all stock awards granted during 2010 would be as follows:
Mr. Boni$309,351; Mr.
Datin$141,760; Mr. Kemmerer$141,760;
Mr. Sisko$113,438; Mr. Zarrilli$113,438. |
|
(4) |
|
The fair value of each stock option is estimated on the date of grant
using the Black-Scholes
option-pricing model. The assumptions used by us in calculating these amounts
are
incorporated by reference to Note 10 to our Consolidated Financial Statements
in our Annual
Report on Form 10-K for the fiscal year ended December 31, 2010. For
2010, the Compensation
Committee awarded a combination of time-based vesting stock options and
performance-based
vesting stock options, which are subject to the same performance-based vesting
conditions as
the PSUs awarded in 2010. The grant date fair values included in this column
for awards that
are subject to performance-based vesting were computed based upon the probable
outcome of the
performance conditions as of the grant date. Assuming the highest level of
performance
conditions will be achieved for the performance-based vesting stock options,
the full grant
date fair value for all stock options
awarded during 2010 would be as follows: Mr. Boni$316,114;
Mr. Datin$144,917; Mr.
Kemmerer$144,917; Mr. Sisko$115,933;
Mr. Zarrilli$115,933. |
41
|
|
|
(5) |
|
For 2010, All Other Compensation includes the following amounts: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Life |
|
|
Group Life |
|
|
|
|
|
|
|
Insurance |
|
|
Insurance |
|
Name |
|
401(k) Matching Contribution |
|
|
Premiums |
|
|
Imputed Income |
|
Peter J.
Boni |
|
$ |
12,250 |
|
|
$ |
30,509 |
|
|
$ |
6,858 |
|
James A.
Datin |
|
|
12,250 |
|
|
|
6,930 |
|
|
|
654 |
|
Kevin L.
Kemmerer |
|
|
12,250 |
|
|
|
4,640 |
|
|
|
419 |
|
Brian J.
Sisko |
|
|
12,250 |
|
|
|
7,420 |
|
|
|
864 |
|
Stephen T.
Zarrilli |
|
|
12,250 |
|
|
|
8,909 |
|
|
|
564 |
|
|
|
|
|
|
Our named executive officers also have occasional personal use of
tickets to various sporting
events at no incremental cost to us and are eligible to receive matching
charitable
contributions under our program, which is available to all employees, subject
to a maximum of
$1,500 in matching contributions for each individual for each calendar
year. |
Each of our
current named executive officers has an employment agreement with us that sets
his
initial base salary and initial minimum annual cash incentive target award.
The initial base
salary and initial minimum annual cash incentive target award for each named
executive officer
employed as of December 31, 2010, were as follows: Mr. Boni
($600,000 salary; $600,000 target
award); Mr. Datin ($375,000 salary; $375,000 target award);
Mr. Kemmerer ($325,000 salary; $325,000
target award); Mr. Sisko ($340,000 salary; $250,000 target award); and
Mr. Zarrilli ($340,000
salary; $195,000 target award). Base salaries and annual cash incentive target
awards, which are
reviewed by the Compensation Committee each year, currently exceed these
contractual minimum
amounts for each named executive officer. The primary focus of these
agreements is to provide our
executive officers with severance benefits in the event of a termination of
employment
involuntarily, for good reason or upon a change in control, as described below
under Potential
Payments upon Termination or Change in Control. The components of
compensation reported in the
Summary Compensation Table, including an explanation of the amount of salary
and cash incentive
compensation in proportion to total compensation, are described in detail
under Compensation
Discussion and Analysis.
42
Grants of
Plan-Based Awards 2010
The following
table shows non-equity and equity incentive plan awards, stock awards and
option awards granted during 2010 to our named executive officers.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
All Other |
|
|
All Other |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock |
|
|
Option |
|
|
|
|
|
|
|
|
|
|
Grant |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Awards: |
|
|
Awards: |
|
|
Exercise |
|
|
Closing |
|
|
Date Fair |
|
|
|
|
|
|
|
|
|
|
|
Estimated Possible
Payouts |
|
|
Estimated Future
Payouts |
|
|
Number |
|
|
Number of |
|
|
or Base |
|
|
Market |
|
|
Value of |
|
|
|
|
|
|
|
Date of |
|
|
Under Non-Equity
Incentive |
|
|
Under Equity Incentive
Plan |
|
|
of Shares |
|
|
Securities |
|
|
Price of |
|
|
Price on |
|
|
Stock and |
|
|
|
|
|
|
|
Comp. |
|
|
Plan Awards (1) |
|
|
Awards (2) |
|
|
of Stock |
|
|
Underlying |
|
|
Option |
|
|
Date of |
|
|
Option |
|
|
|
Grant |
|
|
Committee |
|
|
Threshold |
|
|
Target |
|
|
Maximum |
|
|
Threshold |
|
|
Target |
|
|
Maximum |
|
|
or Units |
|
|
Options |
|
|
Awards |
|
|
Grant |
|
|
Awards |
|
Name |
|
Date |
|
|
Action |
|
|
($) |
|
|
($) |
|
|
($) |
|
|
(#) |
|
|
(#) |
|
|
(#) |
|
|
(#)(2)(3) |
|
|
(#)(2)(3) |
|
|
($/Sh) |
|
|
($/Sh)(4) |
|
|
($)(5) |
|
Peter J.
Boni |
|
|
03/02/10 |
|
|
|
03/02/10 |
|
|
|
|
|
|
|
661,500 |
|
|
|
992,250 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11/05/10 |
|
|
|
11/05/10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10,240 |
|
|
|
15.105 |
|
|
|
15.09 |
|
|
|
78,602 |
|
|
|
|
11/05/10 |
|
|
|
11/05/10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
30,715 |
(6) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15.105 |
|
|
|
15.09 |
|
|
|
107,505 |
|
|
|
|
11/05/10 |
|
|
|
11/05/10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15,360 |
(7) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
105,016 |
|
|
|
|
11/05/10 |
|
|
|
11/05/10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,120 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
77,338 |
|
James A.
Datin |
|
|
03/02/10 |
|
|
|
03/02/10 |
|
|
|
|
|
|
|
401,500 |
|
|
|
602,250 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11/05/10 |
|
|
|
11/05/10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,695 |
|
|
|
15.105 |
|
|
|
15.09 |
|
|
|
36,039 |
|
|
|
|
11/05/10 |
|
|
|
11/05/10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
14,080 |
(6) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15.105 |
|
|
|
15.09 |
|
|
|
49,281 |
|
|
|
|
11/05/10 |
|
|
|
11/05/10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7,040 |
(7) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
48,132 |
|
|
|
|
11/05/10 |
|
|
|
11/05/10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,345 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
35,421 |
|
Kevin L.
Kemmerer |
|
|
03/02/10 |
|
|
|
03/02/10 |
|
|
|
|
|
|
|
387,500 |
|
|
|
581,250 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11/05/10 |
|
|
|
11/05/10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,695 |
|
|
|
15.105 |
|
|
|
15.09 |
|
|
|
36,039 |
|
|
|
|
11/05/10 |
|
|
|
11/05/10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
14,080 |
(6) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15.105 |
|
|
|
15.09 |
|
|
|
49,281 |
|
|
|
|
11/05/10 |
|
|
|
11/05/10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7,040 |
(7) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
48,132 |
|
|
|
|
11/05/10 |
|
|
|
11/05/10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,345 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
35,421 |
|
Brian J. Sisko |
|
|
03/02/10 |
|
|
|
03/02/10 |
|
|
|
|
|
|
|
261,500 |
|
|
|
392,250 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11/05/10 |
|
|
|
11/05/10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,755 |
|
|
|
15.105 |
|
|
|
15.09 |
|
|
|
28,823 |
|
|
|
|
11/05/10 |
|
|
|
11/05/10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11,265 |
(6) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15.105 |
|
|
|
15.09 |
|
|
|
39,429 |
|
|
|
|
11/05/10 |
|
|
|
11/05/10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,630 |
(7) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
38,492 |
|
|
|
|
11/05/10 |
|
|
|
11/05/10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,880 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
28,397 |
|
Stephen T.
Zarrilli |
|
|
03/02/10 |
|
|
|
03/02/10 |
|
|
|
|
|
|
|
261,500 |
|
|
|
392,250 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11/05/10 |
|
|
|
11/05/10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,755 |
|
|
|
15.105 |
|
|
|
15.09 |
|
|
|
28,823 |
|
|
|
|
11/05/10 |
|
|
|
11/05/10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11,265 |
(6) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15.105 |
|
|
|
15.09 |
|
|
|
39,429 |
|
|
|
|
11/05/10 |
|
|
|
11/05/10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,630 |
(7) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
38,492 |
|
|
|
|
11/05/10 |
|
|
|
11/05/10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,880 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
28,397 |
|
|
|
|
(1) |
|
These awards were made under our 2010 MIP. There were no mandatory
minimum awards payable
under our 2010 MIP and the maximum awards payable were 150% of the target
amounts. The
amounts in the table represent payouts that might have been achieved based on
performance at
target or maximum performance levels. Actual payments under these awards,
which have already
been determined and were paid in March 2011, are included in the
Non-Equity Incentive Plan
Compensation column of the 2010 Summary Compensation Table. |
|
(2) |
|
The vesting of equity awards may be accelerated upon death, permanent
disability, retirement
on or after 65th birthday, termination of employment for good reason or
without cause, or
termination of employment in connection with a change in control, and, in the
case of Mr.
Bonis equity awards, upon the occurrence of a change in control. Further
information
regarding the equity awards that are subject to acceleration of vesting in
each circumstance
can be found below under Potential Payments upon Termination or Change
in Control. |
|
(3) |
|
The options and restricted stock vest as to 25% of the underlying
shares on the first
anniversary date of the grant date and as to the remaining 75% of the
underlying shares in 36
equal monthly installments thereafter; the options have an eight-year
term. |
|
(4) |
|
The market price reported in this column is the closing price of
Safeguard common stock as
reported on the NYSE composite tape on the grant date. Under the terms of
Safeguards equity
compensation plans, the exercise price of an option is determined based upon
the average of
the high and low trading prices of Safeguards common stock as reported
on the NYSE composite
tape on the grant date. |
|
(5) |
|
The amounts in this column represent the grant date fair value of the
awards computed in
accordance with FASB ASC Topic 718. The assumptions used by us in calculating
these amounts
are incorporated by reference to Note 10 to our Consolidated Financial
Statements in our Form
10-K. |
|
(6) |
|
As described in detail under Compensation Discussion and
Analysis Long-Term Incentives,
these options are subject to performance-based vesting and vest based on the
aggregate cash
produced as a result of exit transactions involving certain of our partner
companies relative
to the amount of cash deployed in connection with such partner companies over
a 10-year
period. There is no minimum number of option shares potentially exercisable
and the target
amount is the maximum number of shares underlying the options if full vesting
of the options
is achieved. The options have a 10-year term and were granted under our 2004
Equity
Compensation Plan. |
|
(7) |
|
As described in detail under Compensation Discussion and
Analysis Long-Term Incentives,
these PSUs are subject to the same performance-based vesting conditions as the
performance-based vesting options awarded during 2010. Each PSU entitles a
named executive
officer to receive one share of Safeguard common stock on or about the date
upon which the PSU
vests. The PSUs have a 10-year term and were granted under the 2004 Equity
Compensation Plan.
There is no minimum number of PSU shares potentially issuable and the target
amount is the
maximum number of shares underlying the PSUs if full vesting of the PSUs is
achieved. |
43
Outstanding
Equity Awards at Fiscal Year-End 2010
The following
table shows the equity awards we have made to our named executive officers
that were
outstanding at December 31, 2010.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Option Awards |
|
|
Stock Awards |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity |
|
|
|
|
|
|
|
|
|
|
|
|
Equity |
|
|
Incentive Plan |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity |
|
|
|
|
|
|
|
|
|
|
Number |
|
|
Market |
|
|
Incentive Plan |
|
|
Awards: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Incentive Plan |
|
|
|
|
|
|
|
|
|
|
of |
|
|
Value of |
|
|
Awards: |
|
|
Market or |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Awards: |
|
|
|
|
|
|
|
|
|
|
Shares |
|
|
Shares |
|
|
Number of |
|
|
Payout Value |
|
|
|
|
|
|
|
Number of |
|
|
Number of |
|
|
Number of |
|
|
|
|
|
|
|
|
|
|
or Units |
|
|
or Units |
|
|
Unearned |
|
|
of Unearned |
|
|
|
|
|
|
|
Securities |
|
|
Securities |
|
|
Securities |
|
|
|
|
|
|
|
|
|
|
of Stock |
|
|
of Stock |
|
|
Shares, Units |
|
|
Shares, Units |
|
|
|
|
|
|
|
Underlying |
|
|
Underlying |
|
|
Underlying |
|
|
|
|
|
|
|
|
|
|
That |
|
|
That |
|
|
or Other |
|
|
or Other |
|
|
|
|
|
|
|
Unexercised |
|
|
Unexercised |
|
|
Unexercised |
|
|
Option |
|
|
|
|
|
|
Have |
|
|
Have |
|
|
Rights That |
|
|
Rights That |
|
|
|
|
|
|
|
Options |
|
|
Options |
|
|
Unearned |
|
|
Exercise |
|
|
Option |
|
|
Not |
|
|
Not |
|
|
Have Not |
|
|
Have Not |
|
|
|
Grant |
|
|
(#)(1) |
|
|
(#)(1)(2) |
|
|
Options |
|
|
Price |
|
|
Expiration |
|
|
Vested |
|
|
Vested |
|
|
Vested |
|
|
Vested |
|
Name |
|
Date |
|
|
Exercisable |
|
|
Unexercisable |
|
| (#)(2) |
|
|
($) |
|
|
Date |
|
|
(#)(2)(3) |
|
|
($)(5) |
|
|
(#)(2)(4) |
|
|
($)(5) |
|
Peter J.
Boni |
|
|
08/16/05 |
|
|
|
166,666 |
|
|
|
|
|
|
|
|
|
|
|
7.650 |
|
|
|
08/16/13 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
08/16/05 |
|
|
|
143,541 |
|
|
|
|
|
|
|
356,459 |
(6) |
|
|
7.650 |
|
|
|
08/16/13 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
09/30/08 |
|
|
|
28,124 |
|
|
|
21,875 |
|
|
|
|
|
|
|
7.410 |
|
|
|
09/30/16 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
09/30/08 |
|
|
|
|
|
|
|
|
|
|
|
150,000 |
(7) |
|
|
7.410 |
|
|
|
09/30/16 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
02/09/09 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
28,812 |
|
|
|
492,109 |
|
|
|
|
|
|
|
|
|
|
|
|
10/30/09 |
|
|
|
4,558 |
|
|
|
11,067 |
|
|
|
|
|
|
|
9.825 |
|
|
|
10/30/17 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10/30/09 |
|
|
|
|
|
|
|
|
|
|
|
46,875 |
(7) |
|
|
9.825 |
|
|
|
10/30/19 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10/30/09 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
31,250 |
|
|
|
533,750 |
|
|
|
|
11/05/10 |
|
|
|
|
|
|
|
10,240 |
|
|
|
|
|
|
|
15.105 |
|
|
|
11/05/18 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11/05/10 |
|
|
|
|
|
|
|
|
|
|
|
30,715 |
(7) |
|
|
15.105 |
|
|
|
11/05/20 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11/05/10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15,360 |
|
|
|
262,349 |
|
|
|
|
11/05/10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,120 |
|
|
|
87,450 |
|
|
|
|
|
|
|
|
|
James A.
Datin |
|
|
09/07/05 |
|
|
|
83,333 |
|
|
|
|
|
|
|
|
|
|
|
9.360 |
|
|
|
09/07/13 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
09/07/05 |
|
|
|
71,771 |
|
|
|
|
|
|
|
178,229 |
(6) |
|
|
9.360 |
|
|
|
09/07/13 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
09/30/08 |
|
|
|
14,063 |
|
|
|
10,937 |
|
|
|
|
|
|
|
7.410 |
|
|
|
09/30/16 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
09/30/08 |
|
|
|
|
|
|
|
|
|
|
|
75,000 |
(7) |
|
|
7.410 |
|
|
|
09/30/16 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
02/09/09 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
17,904 |
|
|
|
305,800 |
|
|
|
|
|
|
|
|
|
|
|
|
10/30/09 |
|
|
|
2,134 |
|
|
|
5,179 |
|
|
|
|
|
|
|
9.825 |
|
|
|
10/30/17 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10/30/09 |
|
|
|
|
|
|
|
|
|
|
|
21,937 |
(7) |
|
|
9.825 |
|
|
|
10/30/19 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10/30/09 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
14,625 |
|
|
|
249,795 |
|
|
|
|
11/05/10 |
|
|
|
|
|
|
|
4,695 |
|
|
|
|
|
|
|
15.105 |
|
|
|
11/05/18 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11/05/10 |
|
|
|
|
|
|
|
|
|
|
|
14,080 |
(7) |
|
|
15.105 |
|
|
|
11/05/20 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11/05/10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7,040 |
|
|
|
120,243 |
|
|
|
|
11/05/10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,345 |
|
|
|
40,053 |
|
|
|
|
|
|
|
|
|
Kevin L.
Kemmerer |
|
|
06/14/04 |
|
|
|
16,666 |
|
|
|
|
|
|
|
|
|
|
|
14.010 |
|
|
|
06/14/12 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12/15/04 |
|
|
|
20,833 |
|
|
|
|
|
|
|
|
|
|
|
12.750 |
|
|
|
12/15/12 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
06/06/05 |
|
|
|
4,166 |
|
|
|
|
|
|
|
|
|
|
|
6.180 |
|
|
|
06/06/13 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10/25/05 |
|
|
|
8,333 |
|
|
|
|
|
|
|
|
|
|
|
8.280 |
|
|
|
10/25/13 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10/25/05 |
|
|
|
19,139 |
|
|
|
|
|
|
|
47,527 |
(6) |
|
|
8.280 |
|
|
|
10/25/13 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
02/21/06 |
|
|
|
14,354 |
|
|
|
|
|
|
|
35,646 |
(6) |
|
|
11.850 |
|
|
|
02/21/14 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
06/30/08 |
|
|
|
13,021 |
|
|
|
7,812 |
|
|
|
|
|
|
|
7.650 |
|
|
|
06/30/16 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
06/30/08 |
|
|
|
9,364 |
|
|
|
|
|
|
|
53,136 |
(8) |
|
|
7.650 |
|
|
|
06/30/16 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
09/30/08 |
|
|
|
11,717 |
|
|
|
9,115 |
|
|
|
|
|
|
|
7.410 |
|
|
|
09/30/16 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
09/30/08 |
|
|
|
|
|
|
|
|
|
|
|
62,500 |
(7) |
|
|
7.410 |
|
|
|
09/30/16 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
02/09/09 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
13,722 |
|
|
|
234,372 |
|
|
|
|
|
|
|
|
|
|
|
|
10/30/09 |
|
|
|
2,498 |
|
|
|
6,065 |
|
|
|
|
|
|
|
9.825 |
|
|
|
10/30/17 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10/30/09 |
|
|
|
|
|
|
|
|
|
|
|
25,687 |
(7) |
|
|
9.825 |
|
|
|
10/30/19 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10/30/09 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
17,125 |
|
|
|
292,495 |
|
|
|
|
11/05/10 |
|
|
|
|
|
|
|
4,695 |
|
|
|
|
|
|
|
15.105 |
|
|
|
11/05/18 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11/05/10 |
|
|
|
|
|
|
|
|
|
|
|
14,080 |
(7) |
|
|
15.105 |
|
|
|
11/05/20 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11/05/10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7,040 |
|
|
|
120,243 |
|
|
|
|
11/05/10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,345 |
|
|
|
40,053 |
|
|
|
|
|
|
|
|
|
44
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Option Awards |
|
|
Stock Awards |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity |
|
|
Incentive Plan |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity |
|
|
|
|
|
|
|
|
|
|
Number |
|
|
Market |
|
|
Incentive Plan |
|
|
Awards: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Incentive Plan |
|
|
|
|
|
|
|
|
|
|
of |
|
|
Value of |
|
|
Awards: |
|
|
Market or |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Awards: |
|
|
|
|
|
|
|
|
|
|
Shares |
|
|
Shares |
|
|
Number of |
|
|
Payout Value |
|
|
|
|
|
|
|
Number of |
|
|
Number of |
|
|
Number of |
|
|
|
|
|
|
|
|
|
|
or Units |
|
|
or Units |
|
|
Unearned |
|
|
of Unearned |
|
|
|
|
|
|
|
Securities |
|
|
Securities |
|
|
Securities |
|
|
|
|
|
|
|
|
|
|
of Stock |
|
|
of Stock |
|
|
Shares, Units |
|
|
Shares, Units |
|
|
|
|
|
|
|
Underlying |
|
|
Underlying |
|
|
Underlying |
|
|
|
|
|
|
|
|
|
|
That |
|
|
That |
|
|
or Other |
|
|
or Other |
|
|
|
|
|
|
|
Unexercised |
|
|
Unexercised |
|
|
Unexercised |
|
|
Option |
|
|
|
|
|
|
Have |
|
|
Have |
|
|
Rights That |
|
|
Rights That |
|
|
|
|
|
|
|
Options |
|
|
Options |
|
|
Unearned |
|
|
Exercise |
|
|
Option |
|
|
Not |
|
|
Not |
|
|
Have Not |
|
|
Have Not |
|
|
|
Grant |
|
|
(#)(1) |
|
|
(#)(1)(2) |
|
|
Options |
|
|
Price |
|
|
Expiration |
|
|
Vested |
|
|
Vested |
|
|
Vested |
|
|
Vested |
|
Name |
|
Date |
|
|
Exercisable |
|
|
Unexercisable |
|
|
(#)(2) |
|
|
($) |
|
|
Date |
|
|
(#)(2)(3) |
|
|
($)(5) |
|
|
(#)(2)(4) |
|
|
($)(5) |
|
Brian J.
Sisko |
|
|
08/20/07 |
|
|
|
34,722 |
|
|
|
6,944 |
|
|
|
|
|
|
|
12.636 |
|
|
|
08/20/15 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
08/20/07 |
|
|
|
6,770 |
|
|
|
|
|
|
|
118,230 |
(8) |
|
|
12.636 |
|
|
|
08/20/15 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
09/30/08 |
|
|
|
2,953 |
|
|
|
2,297 |
|
|
|
|
|
|
|
7.410 |
|
|
|
09/30/16 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
09/30/08 |
|
|
|
|
|
|
|
|
|
|
|
16,416 |
(7) |
|
|
7.410 |
|
|
|
09/30/16 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
02/09/09 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11,873 |
|
|
|
202,791 |
|
|
|
|
|
|
|
|
|
|
|
|
10/30/09 |
|
|
|
1,058 |
|
|
|
2,567 |
|
|
|
|
|
|
|
9.825 |
|
|
|
10/30/17 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10/30/09 |
|
|
|
|
|
|
|
|
|
|
|
10,875 |
(7) |
|
|
9.825 |
|
|
|
10/30/19 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10/30/09 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7,250 |
|
|
|
123,830 |
|
|
|
|
11/05/10 |
|
|
|
|
|
|
|
3,755 |
|
|
|
|
|
|
|
15.105 |
|
|
|
11/05/18 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11/05/10 |
|
|
|
|
|
|
|
|
|
|
|
11,265 |
(7) |
|
|
15.105 |
|
|
|
11/05/20 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11/05/10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,630 |
|
|
|
96,160 |
|
|
|
|
11/05/10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,880 |
|
|
|
32,110 |
|
|
|
|
|
|
|
|
|
Stephen T.
Zarrilli |
|
|
06/30/08 |
|
|
|
39,063 |
|
|
|
23,437 |
|
|
|
|
|
|
|
7.650 |
|
|
|
06/30/16 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
06/30/08 |
|
|
|
28,091 |
|
|
|
|
|
|
|
159,409 |
(8) |
|
|
7.650 |
|
|
|
06/30/16 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
09/30/08 |
|
|
|
820 |
|
|
|
638 |
|
|
|
|
|
|
|
7.410 |
|
|
|
09/30/16 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
09/30/08 |
|
|
|
|
|
|
|
|
|
|
|
4,375 |
(7) |
|
|
7.410 |
|
|
|
09/30/16 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10/30/09 |
|
|
|
1,058 |
|
|
|
2,567 |
|
|
|
|
|
|
|
9.825 |
|
|
|
10/30/17 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10/30/09 |
|
|
|
|
|
|
|
|
|
|
|
10,875 |
(7) |
|
|
9.825 |
|
|
|
10/30/19 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10/30/09 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7,250 |
|
|
|
123,830 |
|
|
|
|
11/05/10 |
|
|
|
|
|
|
|
3,755 |
|
|
|
|
|
|
|
15.105 |
|
|
|
11/05/18 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11/05/10 |
|
|
|
|
|
|
|
|
|
|
|
11,265 |
(7) |
|
|
15.105 |
|
|
|
11/05/20 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11/05/10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,360 |
|
|
|
96,160 |
|
|
|
|
11/05/10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,880 |
|
|
|
32,110 |
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Unless otherwise identified by footnote, options are subject to
time-based vesting, with 25%
of the underlying shares vesting on the first anniversary date of the grant
date and the
remaining underlying shares vesting in 36 equal installments each month
thereafter. |
|
(2) |
|
Vesting of equity awards may be accelerated upon death, permanent
disability, retirement on
or after 65th birthday, termination of employment for good reason or without
cause, or
termination of employment in connection with a change in control, and, in the
case of Mr.
Bonis equity awards, upon the occurrence of a change in control. Further
information
regarding the equity awards that are subject to acceleration of vesting in
each circumstance
can be found below under Potential Payments upon Termination or Change
in Control. |
|
(3) |
|
Amounts earned under our 2008 MIP by our eligible named executive
officers were paid 50% in
cash and 50% in shares of restricted stock that were issued under our 1999
Equity Compensation
Plan. The shares included in this column that were awarded on February 9,
2009, represent the
shares of restricted stock that were awarded to the eligible named executive
officers under
our 2008 MIP. Those shares vest 25% on the first anniversary date of the grant
date, with
the remaining 75% of the shares vesting in equal monthly installments over the
next 24 months.
The shares included in this column that were awarded on November 5, 2010,
vest 25% on the
first anniversary date of the grant date, with the remaining 75% of the shares
vesting in
equal monthly installments over the next 36 months. |
|
(4) |
|
The PSUs included in this column are subject to performance-based
vesting and vest based on
the aggregate cash produced as a result of exit transactions involving certain
of our partner
companies relative to the amount of cash deployed in connection with such
partner companies
over a 10-year period, as described in detail under Compensation
Discussion and Analysis
Long-Term Incentives. Each PSU entitles a named executive officer to
receive one share of
Safeguard common stock on or about the date upon which the PSU vests. |
|
(5) |
|
Under SEC rules, the value is calculated based on the year-end closing
stock price of $17.08,
as reported on the NYSE composite tape, multiplied by the number of shares or
the number of
shares of stock underlying the PSUs that have not vested. |
45
|
|
|
(6) |
|
These options are market-based vesting options and vest upon the
achievement of improvement
in Safeguards stock price. Achievement is measured based on the average
daily closing price
of Safeguard common stock as reported on the NYSE composite tape for 20
consecutive trading
days. The following table shows the per share stock prices at which portions
of the shares
underlying these market-based vesting options vest: |
|
|
|
|
|
|
|
Per Share Stock Price |
|
Percentage of Shares Underlying Options That Vest |
|
(adjusted to reflect 8/2009 reverse stock split) |
|
First 10% |
|
$ |
12.2154 |
|
Next 20% |
|
$ |
18.9288 |
|
Next 30% |
|
$ |
27.8796 |
|
Final 40% |
|
$ |
39.0684 |
|
|
|
|
|
|
In addition to vesting upon the achievement of a specified per share
stock price, the shares
underlying the options may vest on a pro rata basis on each six-month
anniversary of the grant
date if the per share stock price is between the designated stock prices
(based on the highest
average closing price of a share of our common stock as reported on the NYSE
composite tape for
20 consecutive trading days during each six-month period). |
|
(7) |
|
These options are subject to performance-based vesting and vest based
on the aggregate cash
produced as a result of exit transactions involving certain of our partner
companies relative
to the amount of cash deployed in connection with such partner companies, as
described in
detail under Compensation Discussion and Analysis Long-Term
Incentives. With the
initial award of performance-based vesting options in 2008, the Compensation
Committee
established an initial group of companies which consisted of our partner
companies existing as
of September 30, 2008, other than Clarient, Inc. (Initial
Group), and tied the vesting of
the performance-based options issued in 2008 to predetermined levels of net
proceeds returned
to us based on exit transactions involving the Initial Group. For the 2009
grants, the group
of companies to which performance-based vesting is tied consists of those
partner companies
into which we first deployed capital during the preceding 12 months. For
the 2010 grants, the
group of companies to which performance-based vesting is tied consists of
those partner
companies into which we first deployed capital during the preceding
24 months. |
|
(8) |
|
These options are market-based vesting options and vest upon the
achievement of improvement
in Safeguards stock price. Achievement is measured based on the average
daily closing price
of Safeguard common stock as reported on the NYSE composite tape for 20
consecutive trading
days. The following table shows the per share stock prices at which portions
of the shares
underlying these market-based vesting options vest: |
|
|
|
|
|
|
|
Per Share Stock Price |
|
Percentage of Shares Underlying Options That Vest |
|
(adjusted to reflect 8/2009 reverse stock split) |
|
First 20% |
|
$ |
18.9288 |
|
Next 30% |
|
$ |
27.8796 |
|
Next 40% |
|
$ |
39.0684 |
|
Final 10% |
|
$ |
43.3476 |
|
|
|
|
|
|
In addition to vesting upon the achievement of a specified per share
stock price, the shares
underlying the options may vest on a pro rata basis on each six-month
anniversary of the grant
date if the per share stock price is between the designated stock prices
(based on the highest
average closing price of a share of our common stock as reported on the NYSE
composite tape for
20 consecutive trading days during each six-month period). |
Option
Exercises and Stock Vested 2010
The following
table shows restricted stock awards that vested during 2010. There were no
stock
options exercised by the named executive officers during 2010.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Option Awards |
|
|
Stock Awards |
|
|
|
Number of |
|
|
|
|
|
|
Number of |
|
|
|
|
|
|
Shares |
|
|
|
|
|
|
Shares |
|
|
|
|
|
|
Acquired |
|
|
Value Realized |
|
|
Acquired |
|
|
Value Realized |
|
|
|
on Exercise |
|
|
on Exercise |
|
|
on Vesting |
|
|
on Vesting |
|
Name |
|
(#) |
|
|
($) |
|
|
(#) |
|
|
($)(1) |
|
Peter J.
Boni |
|
|
|
|
|
|
|
|
|
|
37,045 |
|
|
|
433,775 |
|
James A.
Datin |
|
|
|
|
|
|
|
|
|
|
23,021 |
|
|
|
269,564 |
|
Kevin L.
Kemmerer |
|
|
|
|
|
|
|
|
|
|
17,644 |
|
|
|
206,602 |
|
Brian J.
Sisko |
|
|
|
|
|
|
|
|
|
|
15,266 |
|
|
|
178,756 |
|
Stephen
Zarrilli |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
The value realized on vesting is determined by multiplying the number
of shares vested by the
average of the high and low trading prices of Safeguards common stock,
as reported on the
NYSE consolidated tape, on each vesting date. |
Nonqualified
Deferred Compensation 2010
In 2003, Safeguard
adopted an Executive Deferred Compensation Plan, which is a nonqualified,
unfunded plan that provided for a designated group of employees to obtain
credits in the form of
Safeguard contributions that were allocated to accounts for the benefit of
each participant.
Participants were not able to defer compensation under the plan. This plan was
adopted in order to
approximate matching contributions under our 401(k) plan which, based upon the
terms and structure
of our 401(k) plan, were not available to our most highly compensated
personnel.
46
During 2008, the
Compensation Committee approved a change to our 401(k) plan which allowed
matching
contributions for all of our employees beginning in 2009. Therefore, no
contributions were made to
this plan for 2009, and we do not expect to make any future contributions
under this plan. Amounts
accrued for prior periods will remain credited, and earnings on those prior
amounts will continue
to be credited, to prior participants in accordance with the terms of the
plan.
Lump sum
distributions of the vested balance in a named executive officers
account are made
following termination of employment as follows:
|
|
Amounts that were earned and vested at December 31, 2005, are
distributed within 30
business days following termination; and |
|
|
|
The remaining amount is distributed six months following
termination. |
A committee
appointed by Safeguards Board selects the funds or indices that are used
for purposes
of calculating the earnings that are credited to each participants
account based on a notional
investment in the selected funds or indices. Since July 2009, we have
calculated earnings based on
the performance of the notional investment in the Vanguard S&P 500 Index
Fund (VFINX), which is one
of the investment choices currently available to participants in our 401(k)
plan. The committee,
in its discretion, may replace this fund and add new funds.
The following
table shows earnings for 2010 and account balances at December 31, 2010,
for the
named executive officers. There were no withdrawals by, or distributions to,
the named executive
officers during 2010.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Registrant |
|
|
|
|
|
|
|
|
|
|
|
|
Contributions in Last |
|
|
Aggregate Earnings |
|
|
Aggregate Withdrawals/ |
|
|
Aggregate Balance |
|
|
|
Fiscal Year |
|
|
in Last Fiscal Year |
|
|
Distributions |
|
|
at Last Fiscal Year End |
|
Name |
|
($) |
|
|
($)(1) |
|
|
($) |
|
|
($)(2)(3) |
|
Peter J.
Boni |
|
|
|
|
|
$ |
6,802 |
|
|
|
|
|
|
$ |
57,340 |
|
James A.
Datin |
|
|
|
|
|
$ |
6,802 |
|
|
|
|
|
|
$ |
57,340 |
|
Kevin L.
Kemmerer |
|
|
|
|
|
$ |
8,954 |
|
|
|
|
|
|
$ |
75,482 |
|
Brian J.
Sisko |
|
|
|
|
|
$ |
2,953 |
|
|
|
|
|
|
$ |
24,894 |
|
Stephen T.
Zarrilli |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Earnings in the last fiscal year are included in the Summary
Compensation Table under Change
in Pension Value and Nonqualified Deferred Compensation Earnings. |
|
(2) |
|
The balance in each named executive officers account consists of
contributions credited by
us and notional accrued gains or losses. |
|
(3) |
|
At December 31, 2010, Messrs. Boni, Datin and Kemmerer were
fully vested, and Mr. Sisko had a
vested account balance of $20,247. |
Potential
Payments upon Termination or Change in Control
Messrs. Boni,
Datin, Kemmerer, Sisko and Zarrilli each have agreements with us which provide
for
certain benefits upon termination of employment without cause or for good
reason, either
involuntarily or in connection with a change in control. Under these
agreements, the following
definitions apply:
|
|
|
|
|
Cause
|
|
à
|
|
Violation of any of our written policies;
appropriation of a material
business opportunity of our company; misappropriation of company
assets; conviction of a felony or any other crime with respect to which
imprisonment is a possible punishment; or breach of any material term
of the executives employment agreement or any other agreement with, or
duty owed to, us or any of our partner companies. |
|
|
|
|
|
Good
Reason
|
|
à
|
|
A material diminution, without the
executives consent, in the nature
or status of the executives position, title, reporting relationship,
duties, responsibilities or authority; a material reduction of the
executives base salary; a material breach by us of the executives
agreement; the relocation of our principal office by more than 30 to 35
miles; or an executives assignment, without his consent, to be based
anywhere other than our principal office. |
47
|
|
|
|
|
Change in
Control
|
|
à
|
|
A change in control generally occurs
when: |
|
|
|
|
|
|
|
|
|
A person becomes the
beneficial owner of securities having 50%
or more of the combined voting power of our securities; |
|
|
|
|
|
|
|
|
|
Less than a majority
of our Board consists of continuing
directors (which means a director who either is a member of the Board
as of the effective date of the change in control or is nominated or
appointed to serve as a director by a majority of the then continuing
directors); |
|
|
|
|
|
|
|
|
|
We are subject to a
merger or other business combination
transaction as a result of which holders of a majority of our equity
securities do not own a majority of the equity securities of the
surviving company; |
|
|
|
|
|
|
|
|
|
We sell all or
substantially all of our assets or are
liquidated. |
Payments Made
upon Involuntary Termination of Employment without Cause or for Good
Reason
Our named
executive officers will receive the following benefits upon involuntary
termination of
employment without cause or for good reason:
|
|
Messrs. Boni, Datin and Kemmerer: |
|
|
|
A lump sum payment equal to the executives then current annual
base salary and the
greater of the executives target bonus (not less than 100% of current
base salary) for the
year of termination or the average of the executives actual bonuses for
the last three
completed fiscal years; |
|
|
|
All time-vested restricted stock awarded in lieu of all or a portion
of any payout made
under Safeguards Management Incentive Plan will fully vest; |
|
|
|
|
All vested stock options will remain exercisable for 12 months;
and |
|
|
|
|
12 months continued coverage under our medical and dental
plans. |
|
|
Messrs. Sisko and Zarrilli: |
|
|
|
A lump sum payment equal to 1.5 times the executives then
current base salary and the
executives earned prorated bonus for the year of termination; |
|
|
|
All time-vested stock options and restricted stock awards will fully
vest and remain
exercisable for 36 months and vested performance-based stock options will
remain
exercisable for 12 months; |
|
|
|
12 months continued coverage under our medical, dental and
universal life insurance plans; and |
|
|
|
Up to $20,000 for outplacement services or office space. |
Payments Made
upon a Change in Control or Involuntary Termination of Employment without
Cause or
for Good Reason in Connection with a Change in Control
Upon a change in
control, the stock options, restricted stock awards and performance stock
units
held by Mr. Boni that have not otherwise vested will become fully vested.
Our named executive
officers will not be entitled to any other payments or benefits (except those
that are provided on
a non-discriminatory basis to our employees generally upon termination of
employment) unless the
change in control is coupled with a loss of employment or a substantial change
in job duties as
described above.
Upon involuntary
termination of employment without cause or for good reason within six months
before or 12 months following a change in control (for Messrs. Boni,
Datin and Kemmerer) or within
18 months following a change in control (for Messrs. Sisko and
Zarrilli), our named executive
officers will receive the following benefits:
|
|
Messrs. Boni, Datin and Kemmerer: |
|
|
|
A lump sum payment equal to a multiple of the executives then
current base salary and
a multiple of the greater of the executives target bonus (not less than
100% of current
base salary) for the year of termination or the average of the
executives actual bonuses
for the last three completed fiscal years (the multiple is three times for
Mr. Boni and two
times for Messrs. Datin and Kemmerer); |
|
|
|
All stock options, restricted stock awards and performance stock units
that have not
otherwise vested will fully vest and all stock options will remain exercisable
for 36
months for Mr. Boni and 24 months for Messrs. Datin and
Kemmerer; and |
|
|
|
Continued coverage under our medical and dental plans for
36 months for Mr. Boni and 24
months for Messrs. Datin and Kemmerer. |
48
|
|
Messrs. Sisko and Zarrilli: |
|
|
|
A lump sum payment equal to 1.5 times the executives then
current base salary and the
executives earned prorated bonus for the year of termination; |
|
|
|
All time-vested stock options will fully vest and remain exercisable
for 36 months, all
performance-based stock options that have not otherwise vested will vest and
remain
exercisable for 24 months, and all restricted stock awards and
performance stock units that
have not otherwise vested will vest; |
|
|
|
12 months continued coverage under our medical, health and
universal life insurance plans; and |
|
|
|
Up to $20,000 for outplacement services or office space. |
Other Payments
Made upon Termination of Employment
Regardless of the
manner in which a named executive officers employment terminates, he
also
generally will receive payments and benefits that are provided on a
non-discriminatory basis to our
employees upon termination of employment, including the following:
|
|
Amounts earned during his term of employment; |
|
|
|
Upon his death, disability or voluntary termination of employment, his
accrued unused
vacation pay; |
|
|
|
Amounts contributed by us for the year of termination under our 401(k)
plan (if he has
completed the required hours of service, if any, and is an employee on the
date as of which we
make a contribution); |
|
|
|
Distribution of accrued and vested plan balances under our 401(k) plan
and nonqualified
deferred compensation plan; |
|
|
|
Reimbursement of eligible dental expenses for services incurred prior
to termination; |
|
|
|
Upon his death, disability or retirement on or after his 65th
birthday, accelerated vesting
of stock options subject to time-based vesting that have not otherwise vested
and extension of
the post-termination exercise period for all stock options from 90 days
to 12 months; and |
|
|
|
Upon his death or disability, accelerated vesting of restricted stock
awarded in lieu of
all or a portion of any payout made under Safeguards Management
Incentive Plan that has not
otherwise vested; and |
|
|
|
Upon his death or disability, payment of benefits under our other
broad-based employee
benefit programs, including short-term and long-term disability plans, life
insurance program,
accidental death and dismemberment plan and business travel insurance plan, as
applicable. |
The following
table shows the potential incremental payments and benefits which our named
executive
officers would have been entitled to receive upon termination of employment in
each situation
listed in the table below under their respective agreements and our
broad-based employee benefit
programs. The amounts shown do not include certain payments and benefits
available generally to
salaried employees upon termination of employment, such as distributions from
our 401(k) and
deferred compensation plans. The amounts shown in the table are based on an
assumed termination as
of December 31, 2010, and represent estimates of the maximum incremental
amounts and benefits that
would have been paid to each executive upon his termination which we have
calculated: (i) by
multiplying the 2010 annualized base salary for each named executive officer
by the multiplier in
each scenario that is specified in each such executives agreement with
us; (ii) for Messrs. Boni,
Datin and Kemmerer, by multiplying their respective 2010 target incentive
awards by the multiplier
in each scenario that is specified in their respective agreements with us;
(iii) for Messrs. Sisko
and Zarrilli, by assuming they would have been entitled to their respective
2010 annualized target
incentive award for the full year; and (iv) by using our 2011 premium
costs for calculating the
value of the health and welfare benefits. The actual amounts to be paid to
each executive would
depend on the time and circumstances of an executives separation from
Safeguard.
49
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Life Insurance |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accrued |
|
|
Proceeds or |
|
|
Health and |
|
|
Acceleration |
|
|
Total |
|
|
|
Salary and |
|
|
Vacation |
|
|
Disability |
|
|
Welfare |
|
|
of Equity |
|
|
Termination |
|
|
|
Bonus |
|
|
Pay |
|
|
Income |
|
|
Benefits |
|
|
Awards |
|
|
Benefits |
|
Current |
|
($) |
|
|
($) |
|
|
($) |
|
|
($) |
|
|
($)(1) |
|
|
($) |
|
Peter J.
Boni |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Normal
Retirement (65+) |
|
|
|
|
|
|
7,765 |
|
|
|
|
|
|
|
|
|
|
|
312,047 |
|
|
|
319,812 |
|
Permanent disability |
|
|
|
|
|
|
7,765 |
|
|
|
912,500 |
|
|
|
|
|
|
|
804,156 |
|
|
|
1,724,421 |
|
Death |
|
|
|
|
|
|
7,765 |
|
|
|
1,500,000 |
|
|
|
|
|
|
|
804,156 |
|
|
|
2,311,921 |
|
Involuntary
termination without cause or
for good reason |
|
|
1,334,500 |
|
|
|
|
|
|
|
|
|
|
|
10,860 |
|
|
|
492,109 |
|
|
|
1,837,469 |
|
Change
in control |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6,900,354 |
|
|
|
6,900,354 |
|
Change-in-control
termination, involuntarily or
for good reason |
|
|
4,003,500 |
|
|
|
|
|
|
|
|
|
|
|
32,580 |
|
|
|
|
|
|
|
4,036,080 |
|
James A.
Datin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Normal
Retirement
(65+) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Permanent disability |
|
|
|
|
|
|
4,765 |
|
|
|
4,262,780 |
|
|
|
|
|
|
|
458,407 |
|
|
|
4,725,952 |
|
Death |
|
|
|
|
|
|
4,765 |
|
|
|
1,163,000 |
|
|
|
|
|
|
|
458,407 |
|
|
|
1,626,172 |
|
Involuntary
termination without cause or
for good reason |
|
|
814,500 |
|
|
|
|
|
|
|
|
|
|
|
14,073 |
|
|
|
305,800 |
|
|
|
1,134,373 |
|
Change-in-control
termination, involuntarily or
for good reason |
|
|
1,629,000 |
|
|
|
|
|
|
|
|
|
|
|
28,146 |
|
|
|
3,156,637 |
|
|
|
4,813,783 |
|
Kevin L.
Kemmerer |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Normal
Retirement
(65+) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Permanent disability |
|
|
|
|
|
|
4,604 |
|
|
|
3,836,984 |
|
|
|
|
|
|
|
449,455 |
|
|
|
4,291,043 |
|
Death |
|
|
|
|
|
|
4,604 |
|
|
|
1,149,000 |
|
|
|
|
|
|
|
449,455 |
|
|
|
1,603,059 |
|
Involuntary
termination without cause or
for good reason |
|
|
786,500 |
|
|
|
|
|
|
|
|
|
|
|
14,073 |
|
|
|
234,372 |
|
|
|
1,034,945 |
|
Change-in-control
termination, involuntarily or
for good reason |
|
|
1,573,000 |
|
|
|
|
|
|
|
|
|
|
|
28,146 |
|
|
|
2,826,527 |
|
|
|
4,427,673 |
|
Brian J.
Sisko |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Normal
Retirement
(65+) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Permanent disability |
|
|
|
|
|
|
3,490 |
|
|
|
3,294,770 |
|
|
|
|
|
|
|
281,902 |
|
|
|
3,580,162 |
|
Death |
|
|
|
|
|
|
3,490 |
|
|
|
1,113,000 |
|
|
|
|
|
|
|
281,902 |
|
|
|
1,398,392 |
|
Involuntary
termination without cause or
for good reason |
|
|
806,000 |
|
|
|
|
|
|
|
|
|
|
|
38,280 |
|
|
|
314,902 |
|
|
|
1,158,292 |
|
Change-in-control
termination, involuntarily or
for good reason |
|
|
806,000 |
|
|
|
|
|
|
|
|
|
|
|
38,280 |
|
|
|
1,319,304 |
|
|
|
2,163,584 |
|
Stephen T.
Zarrilli |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Normal
Retirement
(65+) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Permanent disability |
|
|
|
|
|
|
4,188 |
|
|
|
3,414,015 |
|
|
|
|
|
|
|
253,219 |
|
|
|
3,671,422 |
|
Death |
|
|
|
|
|
|
4,188 |
|
|
|
1,113,000 |
|
|
|
|
|
|
|
253,219 |
|
|
|
1,370,407 |
|
Involuntary
termination without cause or
for good reason |
|
|
806,000 |
|
|
|
|
|
|
|
|
|
|
|
42,982 |
|
|
|
285,329 |
|
|
|
1,134,311 |
|
Change-in-control
termination, involuntarily or
for good reason |
|
|
806,000 |
|
|
|
|
|
|
|
|
|
|
|
42,982 |
|
|
|
2,151,998 |
|
|
|
3,000,980 |
|
|
|
|
(1) |
|
Under SEC rules, the expense related to the acceleration of equity
awards in each scenario is
calculated as of December 31, 2010, based on (i) the number of
shares underlying stock options
for which vesting would have been accelerated, multiplied by the difference
between our
year-end closing stock price, as reported on the NYSE composite tape, and the
exercise price
of stock options for which vesting would have been accelerated; and
(ii) for restricted stock
awards, the number of shares for which vesting would have been accelerated,
multiplied by our
year-end closing stock price, as reported on the NYSE composite tape; and
(iii) for
performance stock units, the number of shares underlying performance stock
units for which
vesting would have been accelerated, multiplied by our year-end closing stock
price, as
reported on the NYSE composite tape. |
SECTION 16(A)
BENEFICIAL OWNERSHIP REPORTING COMPLIANCE
Section 16(a)
of the Securities Exchange Act of 1934 requires our directors, executive
officers and
greater than 10% holders of our common stock to file with the SEC reports of
ownership of our
securities and changes in ownership of our securities. Based solely on our
review of the copies of
reports we have received and upon written representations from the reporting
persons that no Form 5
reports were required to be filed by those persons, Safeguard believes there
were no late filings
by our directors and executive officers during 2010. There were no known
holders of greater than
10% of our common stock during 2010.
50
OTHER
MATTERS
Expenses of
Solicitation
Safeguard will pay
the entire cost of preparing, assembling, printing, mailing and distributing
these proxy materials and soliciting votes. Upon request, we will reimburse
brokerage houses and
other custodians, nominees and fiduciaries for forwarding proxy materials to
our shareholders. If
you choose to access the proxy materials and/or vote over the Internet, you
are responsible for
Internet access charges you may incur. If you choose to vote by telephone, you
are responsible for
telephone charges you may incur. In addition to the mailing of these proxy
materials, the
solicitation of proxies or votes may be made in person, by telephone or by
electronic communication
by our directors, officers and employees, who will not receive any additional
compensation for such
solicitation.
Procedures for
Submitting Shareholder Proposals
Proposals
for Inclusion in the Proxy Statement. Under Rule 14a-8 under the
Securities Exchange Act
of 1934, as amended, shareholders may present proper proposals for inclusion
in Safeguards proxy
statement for consideration at our next annual meeting of shareholders by
submitting the proposals
to Safeguard in a timely manner. To be included in our proxy statement for our
2012 annual
meeting, shareholder proposals must be received by Safeguard no later than
December 23, 2011. Such
proposals should be sent to:
Safeguard Scientifics, Inc.
Attention: Secretary
435 Devon Park Drive, Building 800
Wayne, PA 19087-1945
Proposals
not included in the Proxy Statement. With respect to proposals not
intended for
inclusion in Safeguards proxy materials for next years annual
meeting, if Safeguard does not
receive notice of such a proposal by March 7, 2012 and the matter is
raised at that meeting, the
proxy holders will have discretionary authority to vote on the matter. All
proposals and
notifications should be addressed to the Secretary at the above address.
Additional
Information
Safeguards
annual report to shareholders for the year ended December 31, 2010,
including
consolidated financial statements and the related notes thereto and other
information with respect
to Safeguard and our partner companies, will be mailed, together with this
proxy statement, on or
about April 21, 2011, to shareholders of record as of the close of
business on April 8, 2011.
General
Our Internet
website address included in this proxy statement is provided for the
convenience of
our shareholders. The information contained therein or connected thereto are
not intended to be
incorporated into this proxy statement. All references to our website address
are intended to be
inactive textual references only.
Safeguard is not
aware of any other business to be presented at the annual meeting. If matters
other than those described in this proxy statement should properly arise at
the annual meeting, the
proxies will use their discretion to vote on such matters.
BY ORDER OF THE
BOARD OF DIRECTORS
Deirdre Blackburn
Secretary
April 13,
2011
51
IMPORTANT ANNUAL MEETING INFORMATION
|
|
|
Using a black ink pen, mark
your votes with an X as shown in
this example. Please do not write outside the designated areas.
|
|
x |
Electronic Voting Instructions
You can vote by
Internet or telephone!
Available 24 hours a day,
7 days a week!
Instead of mailing your proxy, you
may choose one of the two voting
methods outlined below to vote your
proxy.
VALIDATION DETAILS ARE LOCATED BELOW
IN THE GRAY BAR.
Proxies submitted by the Internet or
telephone must be received by 11:59 p.m., Eastern Time, on May 25, 2011.
|
|
|
|
|
Vote by Internet
Log on to the Internet and go to
www.investorvote.com/SFE
Follow the steps outlined on the secured website.
|
|
|
|
|
|
|
Vote by telephone
Call toll free 1-800-652-VOTE (8683) within the USA, US territories & Canada any time on a
touch tone telephone. There is NO CHARGE to you for the call.
Follow the instructions provided by the recorded message.
The cumulative voting
feature for the election of directors is available if you sign and return the proxy or vote in person at the annual meeting; however,
it is not available if you vote by telephone or the Internet.
|
|
|
|
|
Annual Meeting Proxy
Card |
|
|
IF YOU HAVE NOT VOTED VIA THE INTERNET OR TELEPHONE, FOLD ALONG THE
PERFORATION, DETACH AND RETURN THE BOTTOM PORTION IN THE ENCLOSED ENVELOPE.
A |
Proposals The Board
recommends a vote FOR all nominees, FOR Proposals 2 and 3, and for an annual vote on executive compensation.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
+ |
1. |
ELECTION OF DIRECTORSNominees: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For |
|
Withhold |
|
|
|
For |
|
Withhold |
|
|
|
For |
|
Withhold |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
01 - Peter J. Boni
|
|
o |
|
o |
|
02 - Julie A. Dobson |
|
o |
|
o |
|
03 - Andrew E. Lietz
|
|
o |
|
o |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
04 - George MacKenzie
|
|
o |
|
o |
|
05 - George D. McClelland |
|
o |
|
o |
|
06 - Jack L. Messman
|
|
o |
|
o |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
07 - John J. Roberts
|
|
o |
|
o |
|
08 - Robert J. Rosenthal |
|
o |
|
o |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
o
To cumulate votes, write cumulate for in the space below, followed by the name of the nominee(s) and the number of votes to be cast for each nominee.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For
|
|
Against
|
|
Abstain |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2.
|
|
Ratification of
KPMG LLP as the
Companys
independent
registered public
accounting firm for
2011.
|
|
o |
|
o |
|
o |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 Yr
|
|
2 Yrs
|
|
3 Yrs
|
|
Abstain |
3.
|
|
Advisory resolution
concerning the
compensation of our
named executive
officers.
|
|
o |
|
o |
|
o |
|
|
4. |
|
|
Advisory vote
concerning the
frequency of future
advisory votes
concerning
executive
compensation.
|
|
o |
|
o |
|
o |
|
o |
|
|
|
B Non-Voting
Items |
|
|
Change of Address
Please print new address below.
|
|
Comments Please print your comments below.
|
|
|
|
C
Authorized Signatures This section must be completed for your vote to be counted. Date and Sign Below
Please sign exactly as name(s) appear hereon. Joint owners should each sign. When signing as
attorney, executor, administrator, corporate officer, trustee, guardian or custodian, please give
full title.
|
|
|
|
|
Date (mm/dd/yyyy) Please print date below.
|
|
Signature 1 Please keep signature within the box.
|
|
Signature 2 Please keep signature within the box. |
/ / |
|
|
|
|
We are pleased to notify you that Computershare is now the stock transfer agent
and registrar for Safeguard
Scientifics, Inc. Computershare provides you the flexibility to access
information and process transactions
using its toll-free shareholder services center, automated telephone support
system and Internet capabilities.
Contacting Computershare
Effective immediately, please direct your inquiries and transaction
requests to Computershare using the options listed below:
|
|
|
Telephone inquiries:
|
|
1-800-736-3001 (U.S., Canada, Puerto Rico)
1-781-575-3100 (non U.S.)
1-800-952-9245 (TDD) |
E-mail inquiries:
Written requests:
|
|
web.queries@computershare.com
Computershare Investor Services
P.O. Box 43078
Providence, RI 02940 |
Investor Centre
You also can manage your account online via Investor Centre, Computershares Web-based
tool for
shareholders. Here you can view your account details, update your account
information and process various transactions. Registration is quick and easy.
You can access The Investor Centre at
www.computershare.com/investor.
IF YOU HAVE NOT VOTED VIA THE INTERNET OR TELEPHONE, FOLD ALONG THE PERFORATION, DETACH
AND RETURN THE BOTTOM PORTION IN THE ENCLOSED ENVELOPE.
Proxy Safeguard Scientifics, Inc.
THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS OF SAFEGUARD SCIENTIFICS, INC.
No matter how many shares you hold, we consider your vote important and encourage you to
vote as soon as possible. When you sign and return this proxy card, you
|
|
appoint Brian J. Sisko and Deirdre Blackburn (or any substitutes they may appoint), as
proxies to vote your shares, as you have instructed, at the
annual meeting on May 26, 2011, and at any adjournments of that meeting; |
|
|
|
authorize the proxies to vote, in their discretion, upon any other business properly
presented at the meeting; and |
|
|
|
revoke any previous proxies you may have signed. |
IF YOU SIGN AND RETURN THE PROXY BUT DO NOT INDICATE HOW YOU WISH TO VOTE, THE PROXIES WILL
VOTE (1) FOR ALL NOMINEES TO THE BOARD OF DIRECTORS; (2) FOR RATIFICATION OF KPMG LLP AS THE
COMPANYS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR 2011; (3) FOR THE RESOLUTION
CONCERNING THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS, AS DESCRIBED IN THE PROXY
STATEMENT; (4) FOR AN ANNUAL ADVISORY VOTE CONCERNING EXECUTIVE COMPENSATION; AND (5) AS
THEY MAY DETERMINE, IN THEIR DISCRETION, WITH REGARD TO ANY OTHER MATTER PROPERLY PRESENTED
AT THE MEETING.
IN THEIR DISCRETION, THE PROXIES ARE AUTHORIZED TO VOTE UPON SUCH OTHER MATTERS AS MAY
PROPERLY COME BEFORE THE MEETING AND AT ANY ADJOURNMENTS OR POSTPONEMENTS OF THE MEETING.
UNLESS OTHERWISE INSTRUCTED, THIS PROXY WILL BE VOTED IN ACCORDANCE WITH THE RECOMMENDATIONS
OF THE BOARD OF DIRECTORS.
(continued, and to be marked, signed and dated, on the reverse side)